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ABSTRACT 
Sean D. Willis, MS 
Department of Chemistry, December 2012 
University of Kansas 
 
 
The brain is a complex organ, consisting of blood vessels, neurons, neuronal 
support cells, and meninges.  The extracellular space surrounding the neurons is a very 
complex microenvironment, containing proteins, growth factors, neurotransmitters, and 
other small molecules.  Microdialysis has been extensively used for sampling analytes 
from extracellular spaces in tissues.  The microdialysis membrane excludes large 
molecules, making it possible to obtain protein free samples from this space that do not 
require any cleanup steps.  The use of microdialysis allows the sampling of multiple 
analytes in extracellular spaces from multiple regions, making it possible to obtain a 
temporal profile over the time course of an experiment.   
 
High performance liquid chromatography (LC) coupled with ultraviolet (UV) and 
electrochemical (EC) detection makes it possible to analyze samples collected via 
microdialysis with high throughput.  Our lab has developed an LC UV-EC based 
separation and detection method that is capable of the high throughput needed to 
analyze small sample volumes directly from animal studies to study changes in nitric 
oxide synthase (NOS) activity and reactive nitrogen species formation in the brain and 
other tissues with high temporal resolution.   
 
In this thesis, an LC based ion-pair chromatography method is described in 
conjunction with EC and UV detection methods for the determination of primary and 
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secondary products of nitric oxide metabolism (nitrite and nitrate) in the microdialysate.  
The development of an ion-pair based separation and combined UV-EC detection of 
nitrite and nitrate were the fundamental steps for the optimization of separation of nitrite 
and nitrate present in microdialysates.  Detection optimization for nitrite and nitrate was 
carried out in the same matrix as that of perfusate used in animal experiments.  
Separation conditions consisted of 1 mM tetrabutylammonium hydroxide (TBAOH), 15 
mM sulfate at pH 4.0, a flow rate of 0.1 mL/min, using a C-18 4 µM 1x150 mm column 
as the stationary phase.  Microdialysis samples were then injected, separated, and 
detected using LC with UV-EC detection.   
 
 The first application of this method involved monitoring changes in nitrite and 
nitrate concentrations in the rat hippocampus region as a result of chemically-induced 
excitotoxicity.  3-Mercaptopropionic acid (MPA) was perfused through a microdialysis 
probe into the hippocampus brain region of a rat, as had occurred in past studies of our 
research group.  In contrast to the elevation of other biomarkers seen by the 
administration of this compound, this method was unable to detect changes in the 
concentration of nitrite, and the changes found for nitrate appeared to be random. 
 
 The last application of this method involved monitoring changes in nitrite levels in 
a freely moving sheep administered nitroglycerin through infusion and topical 
application to the skin, and histamine injection into the skin.  This study served to further 
validate the developed method for wider application beyond rat brain studies and to 
compare it to a microchip-based amperometric nitrite detection method developed by 
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the S. Lunte research group.  Nitroglycerin infusion produced a response in time course 
experiments that is in agreement by both methods.  Limits of detection, quantitation, 
and sensitivity were higher with this developed method in comparison to the method 
under development by the S. Lunte group.  Furthermore, because this developed 
method was capable of determining nitrite concentrations in microdialysis samples, it 
was used to quantitatively measure nitrite generated during several nitroglycerin 
infusion experiments.  Insufficient response was observed with either nitroglycerin 
topical application, or histamine injection and infusion to warrant further study of nitrite 
production under these conditions. 
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1.1 Introduction 
 
 
1.1.1  Oxidative Stress 
  
Nitric oxide is an important biomolecule that has a multi-pronged role in the 
central nervous system.  It may function as a neurotransmitter, a vasodilatator, or 
react with superoxide under conditions of oxidative stress to form reactive 
nitrogen species (RNS) [1].  Oxidative stress is defined as an imbalance between 
the production and action of reactive oxygen species and the ability of the body to 
easily detoxify reactive intermediates formed or repair the damage resulting from 
these intermediates [2].  Nitric oxide has been found in elevated levels under 
conditions of oxidative stress, such as those of ischemia [3].  Studies have shown 
that under in vitro conditions, nitric oxide reacts with reactive oxygen species such 
as superoxide to form peroxynitrite [4, 5].  Peroxynitrite can react with a variety of 
biological molecules such as DNA bases, lipids, and thiols, causing damage to 
these essential biomolecules.  Because peroxynitrite also reacts with proteins 
containing transition metal centers, oxidizing those metals, iron-containing 
molecules such as hemoglobin, myoglobin and cytochrome P450’s may be 
altered in structure and function [4, 6].  Reaction with amino acids, such as the 
nitration of tyrosine and the oxidation of cysteine, can result from peroxynitrite 
intervention.  These changes can lead to enzyme impairment, changes in 
cytoskeletal structure, and reduced capability of cellular signaling [4].  In addition, 
peroxynitrite is protonated to form peroxynitrous acid under equilibrium conditions, 
followed by nitrogen dioxide and the hydroxyl radical.  The hydroxyl radical is 
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considered the most reactive and damaging reactive oxygen species produced, 
capable of causing damage to molecules such as lipids, proteins, carbohydrates, 
amino acids, and nucleic acids, similar to superoxide.  What makes the hydroxyl 
radical the most damaging is the lack of an enzymatic reaction with which to 
eliminate it.  Superoxide dismutase works to detoxify superoxide to make it 
harmless, while the hydroxyl radical will continue to cause damage over its 
lifetime of 10-9 seconds [7, 8, 9].  Figure 1.1 shows various pathways associated 
with oxidative stress in the brain. 
 
 Because nitric oxide and peroxynitrite have short half-lives of less than 5 
seconds, they are difficult to detect directly [10, 11].  Sensors to detect these 
compounds have been developed, however it is difficult to measure these 
compounds and other biomarkers in the same location simultaneously [12, 13].  
This limitation makes multiple biochemical pathway mapping under oxidative 
stress conditions infeasible.  The need for the development of a method which is 
amenable to detecting nitric oxide production and reactive nitrogen species in the 
presence of other biomarkers, as an added tool for evaluating multiple 
mechanisms of function and damage, is necessary.  Peroxynitrite itself is 
unstable, but will rapidly degrade to form the more stable products nitrite and 
nitrate, which may be monitored off-animal with minimal likelihood of analyte 
degradation [14, 15].  An advantage of  
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Figure 1.1:  Illustration of events leading up to and as a result of oxidative stress 
in the brain.  Influx of Ca2+ as a result of upregulation of ion channels leads to the 
activation of calmodulin and nitric oxide synthase (NOS).  Oxidative stress results 
from the reaction of superoxide with NO to form peroxynitrite (ONOO-), resulting 
in protein, lipid, and DNA damage to the cell and leading to cell death.  Figure 
reproduced with permission from Milhavet, et al. [7]. 
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simultaneously monitoring multiple biomarkers in addition to just nitric oxide 
and/or peroxynitrite is that it provides a map of multiple processes ongoing in the 
brain during oxidative stress.  The described methods in this thesis apply 
minimally invasive techniques which make multiple biomarker evaluation possible 
with high throughput. 
 
 Microdialysis sampling as an analyte collection method is popular for the 
analysis of small molecules and has been used extensively in our research group.  
The advantage of this sampling technique is the ability to monitor multiple 
analytes simultaneously, using off line analysis with multiple established methods.  
In this thesis, development and characterization of methods for the detection of 
nitrite and nitrate from in vivo studies were the central focus.  A rat 3-
mercaptopropionic acid (MPA) model, in which 3-MPA was administered to 
chemically induce seizures, was implemented as the first target of application of 
these methods [16].  The delivery of 3-MPA has been extensively studied by our 
group.   The effect of 3-MPA administration on GABA and glutamate levels has 
been studied as well.  In addition, its role in the formation of lipid peroxidates from 
lipids in neuronal cells by reactive oxygen species (ROS) has been studied in this 
research group.  It was possible that ROS were not the only culprits in the 
formation of lipid peroxides as indicators of damage occurring in cells.    Up until 
this point, reactive nitrogen species (RNS) formation and contribution to oxidative 
stress had not been evaluated, and it was suggested that concentrations of these 
biomarkers should be evaluated as molecules indicative of other pathways under 
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3-MPA administered conditions.  The overall goal of this research was to use the 
developed LC EC method to monitor RNS production in multiple systems and 
animals, with the initial focus on chemically-induced seizure. 
 
1.1.2  Seizure Models 
 
Seizure is predominantly a physical manifestation of the disease epilepsy 
and has a frequency of 1% in the United States (US).  According to 2011 US 
statistics, approximately 3 million of the United States population suffer from 
epilepsy [17].  About 200,000 cases of epilepsy are diagnosed every year, with 
20,000-50,000 deaths as a result of seizures and related causes.   These seizures 
may be caused by fever, low blood sugar from abnormal levels of glucose or 
sodium in the blood, brain damage resulting from stroke, heart disease, head 
injury, aneurysm, or a tumor, as well as infection such as meningitis, or congenital 
in origin.  In addition, withdrawal from certain drugs may exacerbate these events.  
Seizures and related causes result in a per year expenditure of over $15 billion a 
year in treatment costs.  
 
 A seizure can be thought of as an “electrical storm” in specific regions of 
the brain, resulting from hyperneuronal excitation.  This results in rapid neuronal 
firing.  There are many types of seizures, with the most common being associated 
with a “convulsion like” state.  Some seizures display minor to no visible physical 
symptoms.  Symptoms associated with a seizure are dependent upon the brain 
region(s) affected.  Generalized tonic clonic seizures, more commonly known as 
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the “grand mal” type, are dictated by symptoms occurring over the entire body.  
Muscle rigidity, contraction, and loss of consciousness and incontinence are 
typical features of this type of seizure.  Focal seizures are isolated to a single 
region of the brain, and as a result, generate symptoms dictated by the affected 
region.   Muscle contraction, staring and blackout spells, repetitive movements, 
and abnormal sensations are just some of the features of this type of seizure.  A 
seizure can occur due to epilepsy, or be idiopathic (i.e. unknown in origin).  
Treatments are available for many sufferers of epilepsy and other causally 
induced seizures.  It is known, however, that approximately 30% of epileptically 
induced seizures are resistant to current treatments.  In addition, neuro-cognitive 
deficits have been reported by those suffering from this condition.  It has been 
found that patients who have several seizures over time can develop some brain 
damage, and those rapidly experiencing many seizures may experience a rapid 
progression of damage [18].  From a clinical perspective, hippocampal and 
thalamic atrophy, as well as neuronal loss and a reduced ability to function, have 
been reported [19].  The goal of this research is to have a greater understanding 
of what occurs biochemically in the brain under these conditions so that it may be 
possible for more effective treatments for epileptically induced seizures and/or the 
damage they cause.   
 
1.1.3 Seizure and reactive nitrogen species 
 
Nitric oxide (NO) serves as a molecule involved in cellular signaling and as 
a vasodilator in the central nervous system under normal conditions [20].  NO is 
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formed from the reaction of the amino acid L-arginine with the electron carrier 
NADPH and molecular oxygen.  During normal conditions, endothelial and 
neuronal nitric oxide synthase (eNOS/nNOS) derived NO production is limited by 
the amounts present of the NO precursor molecule arginine as well as intracellular 
Ca2+.  eNOS and nNOS activation is Ca2+ dependent, and with a minimal influx of 
this ion, NO production is limited as well.  Ca2+ is necessary for the activation of 
calmodulin, a messenger protein which binds and activates two types of NOS, 
neuronal and endothelial [McMurry 2011, 21].  It has been found that excessive 
levels of NO contribute to the formation of RNS such as peroxynitrite by reaction 
with superoxide [5].  It is these RNS which are believed to contribute to oxidative 
stress.  Peroxynitrite undergoes protonation to form peroxynitrous acid and has 
been found to oxidize protein components such as thiols, amino groups, and 
methionine [5].  In addition, peroxynitrite can form the highly reactive hydroxide 
radical.  It is this radical which is considered the most destructive of all reactive 
species [20, 22, 23].  Furthermore, ATP depletion results, followed by necrosis, 
leading to the rupture and death of the cell as shown in Figure 1.1 [7, 24,25].  As 
a result of cellular necrosis, an inflammatory response is generated, resulting in 
the activation of leukocytes and inflammatory molecules that cause membrane 
blebbing (i.e. irregular bulging due to cytoskeleton decoupling) in the surrounding 
cells and an increase in NO, leading to further RNS production [26, 27, 28, 29]. 
 
1.2  Methods 
1.2.1  High Performance Liquid Chromatography 
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High performance liquid chromatography (LC) is a popular analytical 
technique implemented in the 1960’s for the separation of a wide variety of 
compounds [30].  Recently, LC has been applied toward solving a plethora of 
biochemical/clinical, forensic, environmental, food, and pharmaceutical related 
problems [31].  Columns consisting of dimensions of internal diameters (i.d.) of 1-
2 mm and lengths ranging from 50-150 mm make it possible to use sample 
injection volumes as small as several microliters, making current LC amenable to 
analyzing small sample volumes [32].  These low injection volumes make it 
possible to perform multiple separate LC analyses of microdialysis samples.     
LC has several advantages over other separation methods such as capillary 
electrophoresis (CE).  Lifetimes of liquid chromatography columns are much 
higher than capillaries used in CE.  In addition, variability in retention time with LC 
is also significantly lower in comparison to CE methods.  Furthermore, LC is more 
compatible with high ionic strength samples.   
 
A common LC system consists of a high pressure pumping system, of which is 
connected to an injection valve, followed by a chromatographic column 
responsible for analyte separation, and a detection system (UV-VIS, EC, mass 
spectrometer) as shown in Figure 1.2 [33].  The first step in LC is the pumping of 
mobile phase responsible for analyte transport from a reservoir to the injection 
valve and into the chromatographic column.  Sample is introduced into the system 
at the injection valve, resulting in the transport of the sample plug onto the 
chromatographic column.  This process is followed by a separation process on 
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Figure 1.2:  LC and detection schematic [33] 
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the chromatographic column where analytes are separated based upon their 
degree of interactions with the stationary phase.  Chromatographic separation, in 
general, depends upon a variety of factors.  Flow rates, mobile phase, and 
stationary phase conditions all play a role in compound separation.  
 
In theory, chromatography works based upon distribution of analytes 
between phases.  A theoretical plate model helps to explain ongoing processes in 
a column during chromatographic separation.  In addition, it is used as a method 
to measure column efficiency in practice.  The number of theoretical plates (N) is 
the most commonly reported value of column efficiency, with a higher efficiency 
associated with a larger N value:  N 2
1 / 2
2
R
w
5. 55t
 , where tR is the retention time of the 
peak of interest and w1/2 is the width at half-height of this peak [34].  The number 
of plates for a column is dependent upon the width of the peak of an analyte in a 
separation.  A narrower analyte peak allows for not only maximization of 
resolution between it and other peaks present, but for equivalent peak areas, 
maximization of peak height, with the greater the peak height for an analyte at any 
given concentration, the lower the potential limits of detection for that analyte.  
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Resolution is the degree of separation between two peaks in a 
chromatogram and is defined as:  
 
Rs 
2(t r 2 t r 1)
w1w2
, where tr1 and tr2 represent the 
difference in retention times of the two peaks and w1+w2 represent the addition of 
the peak widths of the two peaks at the base.  A resolution of >1.5 is desired for 
complete baseline resolution [35].  
 
1.2.2  Reverse Phase (Partition) Chromatography 
In this development of chromatography, the column contents consist of a 
solid support covered by a covalently attached stationary phase (bonded phase).  
Analyte equilibrates between this phase and the mobile phase moving through the 
column.  It is due to this equilibrium state that different analytes are separated.  All 
analytes are traveling at the same speed through the mobile phase; however, the 
greater the affinity of the analyte for the stationary phase, the more time it will 
spend in the stationary phase in comparison with analytes of lesser affinity [36].  
The ability of analytes to be separated based upon stationary and mobile phase 
conditions can be stated as a result of differences in partition coefficients.  This 
coefficient is a mathematical ratio of the concentrations of an analyte present in 
two phases of a mixture consisting of two solvents which are immiscible with one 
another, all at equilibrium [37].   
 
In the case of partition chromatography, one phase is the bonded 
stationary phase, and the other phase is the mobile phase.  The stationary phase 
for reversed phase chromatography is considered hydrophobic/lipophilic, and the 
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mobile phase is considered hydrophilic/lipophobic [38].  Due to the relationship of 
“like dissolves like”, the partition coefficient can be viewed to be a measure of the 
affinity of analyte for a hydrophobic phase over that for a hydrophilic phase, or the 
hydophobicity of an analyte [39].  For partition chromatography involving a 
hydrophobic stationary phase and hydrophilic mobile phase, the partition 
coefficient of a particular analyte would be its concentration in the stationary 
phase over that in the mobile phase. 
 
Reversed phase chromatography can apply a wide variety of hydrophobic 
stationary phases to separate analytes.  The general form of these hydrophobic 
phases is the presence of alkyl chains bonded to a resin support containing 
silanol groups.  The most common alkyl group used for reversed phase 
chromatography is the octadecyl (C-18) group [40].  Less common alkyl groups 
used are octyl (C-8) and phenyl based groups.  In addition, any exposed silanol 
group may have various organic groups added to increase selectivity of the 
stationary phase.  The more hydrophobic an analyte is, the more strongly it will 
bind to these groups of the stationary phase, separating it from the more 
hydrophilic compounds eluted first from the column.  Figure 1.3 shows this 
process [40].  The composition of the mobile phase is important as well.  Organics 
soluble in water are commonly used in mobile phases to elute analytes strongly 
bound to the hydrophobic stationary phase, and may be used in a constant 
concentration or added as a gradient [41].              
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Figure 1.3:  Reversed phase separation of various analytes based upon their 
hydrophobicity, as a result of the degree of their interactions with the hydrophobic 
stationary phase.  Reproduced by permission of Restek Corporation. 
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1.2.3  Ion-Exchange Chromatography 
 
In this type of chromatography, a negatively or positively charged ion is 
covalently attached to a solid stationary phase consisting of a resin.  Analyte 
molecules of an opposite charge traveling in mobile phase are attracted 
electrostatically to the charged ions of the stationary phase, as shown in Figure 
1.4.  The degree of attraction of molecules for this ion exchanger is dependent 
upon the degree of electrostatic attraction due to the magnitude and location of 
opposite charges [42].  To bind an analyte to the stationary phase, it is typically 
introduced as a sample in mobile phase of low ionic strength.  The molecules can 
then be eluted by increasing the concentration of similarly charged species in the 
mobile phase which compete with the analyte for the ion exchanger, or shield the 
analyte from the exchanger and allow it to elute.  The use of a gradient of 
increasing ionic strength makes it possible to separate several analytes, with 
analytes possessing weaker ionic interactions with the ion exchanger being eluted 
earliest [42, 43].  
 
In addition, pH may be altered to elute charged analytes attracted to the ion 
exchanger.  In the case of cation-exchange chromatography, where the ion 
exchanger is negatively charged and the analyte is positively charged, an 
increase in pH will make the analyte neutral or negatively charged, reducing or 
eliminating its electrostatic attraction and allowing it to elute from the column.  
With anion-exchange chromatography, the opposite is the case.  Negatively 
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charged analytes will be eluted from the positively charged ion exchanger by 
lowering mobile phase pH, protonating the negatively charged groups of the 
analyte and reducing or eliminating its electrostatic attraction for the exchanger 
and allowing it to elute from the column [44].  To retain the analyte on the ion 
exchanger, the pH of the mobile phase must be between the pKa of the analyte 
and that of the charge ion exchanger [45]. 
 
1.2.4  Ion-Pairing Chromatography 
 
Ion-pair chromatography is a mobile phase modification that allows a 
reversed-phase column (typically C-18) to separate ionic analytes which would 
typically not be retained otherwise.  Modification of the mobile phase occurs 
through the addition of an ion-pair reagent as a component.  Common reagents 
include tetra-alkylammonium, alkyl sulfates, alkyl sulfonates, and trifluoroacetic 
acid.  Tetrabutylammonium hydroxide, a tetra-alkylammonium, was used as the 
ion-pair reagent in this research and is shown in Figure 1.5 [44]. Typically without 
such a compound present, negatively charged and positively charged analytes 
are retained the least and are too close to one another to distinguish them in a 
chromatogram, while neutral analytes are retained relatively longer [45, 46, 47, 
48].   
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Figure 1.4:  Ion exchange analyte separation based upon electrostatic attraction.  
Oppositely charged ions of analyte are attracted to the ion exchanger for 
retention.  Reproduced by permission of Waters Corporation.  
 
 
 
 
 
 
  
 
 
17 
 
The type of the ion-pair reagent, such as its charge and hydrophobicity, 
dictate interactions.  When an ion-pair agent is added to the column environment, 
the hydrophobic groups adsorb to the column stationary phase, leaving the 
charged head group free to interact with charged analytes transported through the 
column.  In addition, the type of analyte influences the degree of interaction with 
the ion-pair head groups and hydrophobic stationary phase.  Like charges repel 
like charges, meaning that analytes with the same charge as that of the ion-pair 
head group will interact the least and will be repelled from those groups on the 
stationary phase.  As a result, these analytes will be retained the least on the 
column.  Neutral charged molecules do not interact with the charged head groups 
of the ion-pair reagents; however, because they are not repelled as like charges 
are, they have the opportunity to interact with the hydrophobic regions of the 
stationary phase, making them retained longer on the column than like charged 
analytes.  Molecules with charges of opposite polarity of the ion-pair head group 
will be retained the longest on the column as a result of two factors:  the opposite 
charge of the analyte will cause it to electrostatically interact with the ion-pair head 
group, and hydrophobic regions of the analyte will interact with the hydrophobic 
region of the stationary phase [45, 46, 47, 48]. 
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Figure 1.5:  Ion-pairing reagent tetrabutylammonium hydroxide [44]. 
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The interactions of counter ions with those of the ion pairing reagent on the 
stationary phase surface follow the electrical double layer model, shown in Figure 
1.6 [49].  Ions are not distributed linearly next to the surface of these agents with 
the remainder distributed randomly, but are ordered such that the counter ions are 
distributed to generate the least amount of energy in an equilibrium state.  An 
electrostatic potential is generated due to the difference in charge polarity.  This 
potential is dependent upon the concentration of ion pairing reagent on the 
surface [50].  The Gouy-Chapman theory assumes the surface potential is a 
function of the charge density of the surface as well as the ionic strength of the 
analyte of interest.  This means that the greater the charge density of the ion 
pairing reagent head groups and the higher the analyte ionic strength, the higher 
the surface potential.  In this case, the ion pairing agent interaction with the 
stationary phase assumes a charged, planar surface.   
 
In addition to its charge state, the concentration of ion-pairing reagent has 
an effect upon the retention of analytes.  A critical concentration of the reagent is 
necessary such that the analyte is retained long enough for separation, however 
not so much that analyte retention is reduced.  Once the ion-pair reagent adsorbs 
a maximum number of hydrophobic stationary phase locations, excess of this 
reagent flows through the column and is eluted.  If too high of a concentration of 
ion-pair reagent is present in the mobile phase, analyte will interact more with this 
reagent that is flowing through and less with that adsorbed to the column 
stationary phase.  
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Figure 1.6:  Electrical double layer model for ion pair reagent chromatography.  In 
this picture, the ion pair reagent is depicted as negatively charged head groups 
with hydrophobic tails.  The analyte of interest in this case is Na+.  The reversed 
phase portion of the stationary phase is shown as the layer between the silica 
substrate and the negatively charged head groups of the ion pairing reagent at the 
reversed phase outermost surface [49] 
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A result is a reduction of retention time for the analyte of interest, which may 
negatively affect the separation.    
 
The presence of an organic modifier as well as its concentration in the 
mobile phase affects the performance of ion-pair reagents [51].  Modifiers such as 
methanol or acetonitrile tend to interact with the hydrophobic regions of the 
reagent as well as the stationary phase, resulting in the reduction of ion pair 
reagent adsorption to the column stationary phase and retention of analytes of 
interest.  Modifiers such as carboxylic acids above their pKa values will be 
negatively charged and interact electrostatically with the positively charged ion-
pair head groups; in addition their hydrophobic regions interact with the stationary 
phase and ion-pair reagent hydrophobic groups.  A result is a reduction in the 
number of sites available for analyte electrostatic and hydrophobic interactions, 
leading to a reduction in retention time of the analytes of interest. 
  
Ionic strength and the type of ions in the mobile phase additionally has an 
effect upon ion-pair separation [51, 54].  Competition with the analyte for the ion-
pair head group can reduce analyte retention, affecting the separation.  This may 
be beneficial or not for the analysis.  Retention of analytes on the column for too 
short a period of time may result in co-elution with other compounds.  On the 
other hand, retention of analytes for too long can result in significant peak 
broadening leading to co-elution with other compounds.      
1.2.5 Electrochemical detection 
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Electrochemical (EC) detection relies upon the induction of a chemical 
reaction by an applied voltage and the measurement of electron transfer as a 
result of this reaction.  This detection method was developed originally for the 
detection of the catecholamines, which are aromatic compounds present in the 
central nervous system and are partially responsible for its function [54, 55].  
Advantages of EC detection are low limits of detection, high sensitivity, and high 
selectivity.  This method functions based upon the detection of easily oxidized or 
reduced analytes.  Amperometry or fixed potential EC detection is the most 
common form of this type of detection method, allowing for the identification and 
quantitation of electrochemically active analytes.   
 
An EC system is typically composed of a potentiostat that acts as a voltage 
delivery source, and a flow-through EC cell where the oxidation or reduction 
process occurs for the analyte identification and quantitation as the mobile phase 
is delivered from a LC system.  The EC cell is made up of 3 electrodes, a working 
electrode, counter electrode, and reference electrode.   The working electrode 
serves as the site where the analyte of interest is oxidized or reduced.   The 
counter electrode serves as a site to which a potential difference from the working 
electrode is applied and will serve as a cathode during oxidation reactions and as 
an anode during reduction reactions [54, 55, 56].  The reference electrode 
contains a well-known, stable potential.  This quality allows it to be used to 
account for measuring the potential drop between the working electrode surface 
and the solution.  A commonly used reference electrode is the silver chloride 
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(Ag/AgCl) type, with a standard potential of +0.210V at 3.0 mol/kg KCl [57, 58, 
59]. Shown in Figure 1.7 is a response versus applied potential plot 
(hydrodynamic voltammogram) for a glassy carbon working electrode versus 
Ag/AgCl detection of nitrite using an electrochemical flow cell.    
 
1.2.6 Ultraviolet-Visible (UV-Vis) Spectroscopy 
UV-Vis spectroscopy is reliant upon absorption, which is proportional to the 
path length of the solution containing the absorbing molecule and the 
concentration of the molecule.  Linking absorbance as a detection method to LC 
requires the use of a spectrophotometer composed of a flow cell, a light source(s), 
a diffraction grating which selects for a specific wavelength(s) to enter the flow 
cell, a half mirror responsible for directing some incident light to get an initial 
intensity reading by a detector, and a second detector behind the flow cell 
receiving transmitted light.  From the collection of the intensities of the incoming 
and transmitted light by the two detectors, the UV-Vis detection system can 
determine an absorbance value.   Figure 1.8 shows a UV-Vis spectrum of 
absorbance intensity versus wavelength, with maximum absorbance intensity at 
200nm and minimum absorbance intensity at 235nm.  
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Figure 1.7:  Hydrodynamic voltammogram of nitrite, showing an increase in 
response from 700mV up to 1100mV.   
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Figure 1.8:  UV-VIS-vis spectrum of nitrate showing a decrease in response from 
200nm to 235nm. 
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1.2.7 Microdialysis collection 
 
Microdialysis is a method of sampling which allows for continuous and 
direct collection of compounds around the implanted probe.  It is advantageous for 
in vivo studies due to its ability to monitor multiple analytes simultaneously in 
animals under anesthesia or that are awake and mobile.  Samples collected lack 
proteins, increasing sample stability and reducing or eliminating sample cleanup 
prior to analysis.  In addition, probes used for sample collection may be also used 
for delivery of compounds that are pharmacologically relevant to the study, 
eliminating additional implantation procedures.  Probes are composed of a 
dialysis membrane sandwiched between an inner and outer tube comprising the 
cannula.  The membrane itself can vary in length as well as composition, with its 
construction material dictating the molecular weight cutoff of sampled analytes, 
ranging from 20-100 kDa.  Probes are perfused with solutions that match the tonic 
characteristics of the sampling environment as closely as possible.  For brain 
studies, probes used consist of a cylindrical tube, with a tip at which a variable 
length dialysis membrane is attached.  The recovery of the analyte of interest is 
dependent upon analyte molecular weight, with a rapid reduction in recovery if 
molecular weight exceeds ¼ of the cutoff of the microdialysis membrane.  In 
addition, the solubility of the analyte dictates diffusion ability across this 
membrane.  Water-soluble compounds such as glucose cross freely, while 
lipophilic compounds such as oleate present in fats have a reduced capability of 
membrane crossing [60, 61, 62].  Artificial cerebral spinal fluid or Ringer’s solution 
is perfused through the probe to the microdialysis membrane where it picks up 
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analytes which have diffused into the probe from the surrounding environment, as 
shown in Figure 1.9 [63].  
 
Microdialysis is a two direction process.  Sampling using microdialysis is 
not an equilibrium based process, and as result, analytes collected are 
representative of the concentrations sampled in the tissues.  These 
representations are fractions of the concentrations present in the probe sampling 
environment, and can be expressed as efficiencies.  Extraction efficiency (EE) is 
the most common method used to describe probe performance and is defined as 
the analyte exchange rate across the microdialysis membrane.  In other words, 
EE represents the difference between the loss and gain of an analyte (Cp-Cd) over 
the difference in concentration of the perfusate and that of the sampling site (Cp-
Cs), or 
sp
dp
CC
CC
EE


 .  EE is independent of the analyte concentration at steady-
state, as concentrations collected may be variable with constant flow rates, or the 
use of a single concentration at variable flow rates results in EE’s of the same 
value.  The ratio of (Cp-Cd) and (Cp-Cs) remains the same [62].  
 
Compounds possessing higher concentrations of the analyte of interest in 
the perfusate pumped into the probe will display a net movement out of the probe 
unit area per unit time, or delivery.  In contrast, compounds that have a higher 
concentration in the site surrounding the probe display a net movement into the 
probe unit area per unit time, defined as recovery.    These processes occur with 
no net loss of fluid from the sampling site [64, 65].  Relative recovery is dependent 
28 
 
upon a number of factors, such as analyte composition, probe membrane 
composition and length or diameter, as well as perfusate flow rate [58, 59].  The 
relative recovery for an analyte is determined by sampling it from an in vitro 
environment using microdialysis and a perfusate of composition as similar to the 
tonic quality of the unadulterated sampling environment as possible.  The 
equation needed to determine probe recovery is determined using extraction 
efficiency in recovery mode:  RE = %100
. x
C
C
s
d .  In this equation, dC is the 
concentration of analyte recovered in the dialysate and sC  is the concentration of 
analyte in the sampling environment.  The relationship between flow rate and 
analyte relative recovery is an inverse one.  Analyte recovery is greatest at sub 
1µL/min sampling rates, however temporal resolution suffers at such low values.  
On the other hand, high rates of perfusion, approaching 5µL/min, result in 
substantial reduction in relative recovery.  Flow rates are selected to maximize 
analyte recovery, at the same time allowing for sufficient sample sizes and 
temporal resolution for analysis.  Common sampling rates vary from 0.1 to 5.0 
µL/min [66, 67].  
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Figure 1.9:  Microdialysis probe used for sampling from the rat brain.  Note that 
diffusion occurs across the membrane due to an analyte gradient with no net fluid 
loss.  Reproduced by permission of Chaurasia, et al. [63]. 
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1.3 Objectives 
The primary objective of this research was to develop chromatographic 
separations and UV-Vis-EC detection methods to identify and quantify the 
compounds nitrite and nitrate, with a goal of using microdialysis sampling to 
measure compounds in brain and subcutaneous tissue.  Separation optimization 
experiments were carried out using nitrite and nitrate standards dissolved in 
mobile phase, followed by a solution of identical composition as basal perfusate 
expected to be used under in vivo conditions.  Basal dialysate samples from in 
vivo experiments were then spiked with nitrite and nitrate standards to optimize 
their separation from other endogenous compounds present under in vivo 
conditions.   
 
Microdialysis was used to monitor the formation and concentration of stable 
end products indicative of RNS generation under conditions of oxidative stress.  
Epileptic seizures induce the formation of lipid peroxidates as a result of cellular 
damage under conditions of oxidative stress.  However, the role of RNS has not 
been specifically studied under these conditions as presented by the 3-MPA 
model.  In further studies, chromatographic conditions were optimized for the 
presence of 3-MPA and its artifacts.  In addition, NOS upregulation and RNS 
formation were studied in subcutaneous regions of sheep in response to 
administration of histamine injection, nitroglycerin cream, and nitroglycerin 
perfusion.  A LC-UV method was also modified to detect and quantify 
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nitroglycerin, to support microdialysis delivery studies. Discussion of these 
experiments will occur in greater detail in the following chapters.    
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2.  Methods 
 
2.1 Introduction 
 
Nitrite and nitrate have been separated using capillary electrophoresis and 
detected with UV-absorbance or fluorescence following derivatization [1].  
However, using these methods to detect both nitrite and nitrate is problematic.  
UV-absorbance detection is not an amenable method for nitrite quantitation in vivo 
as the compound is present in sub-micromolar concentrations.  Furthermore, 
derivatization of these analytes to produce a fluorescent compound requires 
larger sample volumes as well as steps needed to reduce nitrate to nitrite.  Nitrite 
and nitrate have been separated by LC and detected by UV-absorbance and EC 
methods [2, 3].  Figure 2.1 shows the instrumental setup for analysis of these 
compounds.  The advantage of using these methods of separation and detection 
is the elimination of sample preparation steps, allowing for a high throughput 
analysis.  In this thesis, LC-EC-UV was used to separate, identify, and quantify 
these analytes.  In addition, in vitro studies were conducted with a nitric oxide 
donor used by the S. Lunte research group.  
 
2.2 Objectives 
The purpose of this research was to develop an LC-EC-UV method 
capable of separating and detecting secondary products of RNS in microdialysis 
samples.  Optimizations of nitrite and nitrate detector parameters were 
accomplished to allow for the lowest detection limits possible.  Nitrite and nitrate  
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Figure 2.1:  Schematic of LC-EC-UV instrument setup.  
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standard separation and retention times were optimized to allow for identification 
and quantitation in microdialysis samples.  In addition, microdialysis probe 
calibration was conducted to determine more realistic in vivo concentrations of 
nitrite and nitrate.  Finally, an in vitro investigation of NO release from a donor 
evaluated the ability of the method to indirectly detect RNS formation by analysis 
of stable secondary products was performed.     
 
2.3 Nitric oxide product standard separation and detection, and separation 
of basal microdialysis samples 
          
 
2.3.1 Optimization of nitric oxide primary and secondary product standard 
separation 
 
Studies were first conducted using nitrite and nitrate standards in mobile 
phase using LC-UV (SPD-10A, Shimadzu Corp., Kyoto, Japan) to determine their 
retention times as well as peak efficiencies and resolution.  The column used was 
a Phenomenex ® Synergi 4 µm Hydro-RP 80 Å (Phenomenex, Torrance, CA) with 
dimensions of 2 mm x 250 mm.  The mobile phase was 1 mM 
tetrabutylammonium hydroxide (TBAOH) and 10 mM sodium acetate at a pH of 
5.0.  Mixtures of nitrite and nitrate in mobile phase were injected for the analysis 
using a Rheodyne ® 7725i injector (IDEX Health & Sci., Rohnert Park, CA).  The 
use of an ion-pair reagent allowed for sufficient retention of polar, hydrophilic 
nitrite and nitrate beyond the void volume, allowing for separation, identification, 
and quantitation of these compounds.  The purpose behind using acetic acid was 
to influence the degree of interaction of nitrite/nitrate and the charged head 
groups of the ion-pair reagent, and to serve as an electrolyte for the 
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electrochemical system next in line for development.  The pH of the mobile phase 
was increased beyond that of the pKa of acetic acid (4.74), allowing for a majority 
(66%) of this compound to be present as the conjugate base needed for 
conduction in the electrochemical system.   Separation of nitrite and nitrate was 
achieved.  Because the eventual goal was to work in a biological matrix with many 
other compounds, it was desired to optimize mobile phase conditions further.  The 
goals of additional optimization were to reduce the time required for a 
chromatographic run and allow for the sharpest peak shape and highest 
resolution possible.  It became necessary to reduce the concentration of TBAOH 
(0.5 mM) and increase the concentration of acetate (50 mM) to ensure that 
adequately separated nitrite and nitrate peaks were eluting in under 10 minutes.  
Figure 2.2 shows these separations.   
 
Acetate appeared to have the greatest influence on the retention times of 
nitrite and nitrate.  It was finally decided to increase the acetate concentration to 
100mM to accomplish the separation accomplished in about 5 minutes.  The 
presence of this organic acid acted to reduce the extent of interaction of nitrite and 
nitrate with the ion-pair modified stationary phase.  As a result of molecular 
structure, charge distribution, and size differences, nitrate had a longer retention 
time than nitrite.  At pH 5.0, acetate was sufficiently deprotonated, leaving it free 
to compete with nitrite and nitrate for the positively charged ion-pair modified 
stationary phase and reducing the retention times of these analytes as a result.  
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Figure 2.2:  Chromatograms of nitrite and nitrate standards injected.  The graph 
is an overlay of the UV chromatograms showing a reduction of retention times for 
nitrite and nitrate standards as well as reductions in peak widths of each analyte.  
Standards are in mobile phase at a flow rate of 0.4 mL/min. and are detected at a 
wavelength of 220 nm.  Traces are:  (a) 1 mM TBAOH, 10 mM acetate, pH 5.0; 
(b) 0.5 mM TBAOH, 10 mM acetate, pH 5.0; (c) 0.5 mM TBAOH, 50 mM acetate, 
pH 5.0; (d) 0.5 mM TBAOH, 50 mM acetate, pH 6.0; (e) 0.5 mM TBAOH, 100 mM 
acetate, pH 6.0.  
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Overlays of nitrite and nitrate as a result of mobile phase optimization are shown 
in Figure 2.2. 
 
2.3.2 Optimization of nitric oxide secondary product detection and 
separation in mobile phase and Ringer’s solutions 
The EC system consisting of an electrochemical cell, CC-5 faradaic cage, 
and LC-4C amperometric detector (Bioanalytical Systems Inc., West Lafayette, 
IN) was set up initially with an applied potential of +0.750 V as an initial proof of 
concept.  After running additional hydrodynamic voltammograms, it was decided 
to increase the applied potential of the EC system to +1.0V and the pH of the 
mobile phase to 6.0.  The specific reason this change was made was to give a 
greater response in the electrochemical system.  Increasing the pH of the mobile 
phase deprotonated more of the acetic acid, increasing the concentration of the 
electrolyte acetate form.  Retention times were insignificantly affected, most likely 
due to a lack of significant equilibrium conditions disruption with ion-pair reagent 
adsorbed to the stationary phase.  In addition, increasing the applied potential of 
the amperometric detector allowed for greater oxidation of nitrite.  Maximizing 
detector response for an analyte is desired, to allow for the lowest detection limits 
possible.  Figure 2.3 shows a comparison of the effects of pH and applied 
potential changes upon detector response for a nitrite standard.  Both an increase 
in pH and applied potential increased the oxidation of nitrite.  The ultimate goal of 
mobile phase modifications was to separate nitrite and nitrate and detect the 
lowest concentrations possible of nitrite in Ringer’s solution or artificial cerebral  
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Figure 2.3:  Overlays of chromatograms comparing changes in amperometric 
detector response as a result of increasing mobile phase pH and applied potential 
at a flow rate of 0.4 mL/min.  In the top overlay, trace (a) consists of nitrite 
standard dissolved in and injected using mobile phase composed of 50 mM 
acetate and 0.5 mM TBAOH at a pH of 5.0.  Trace (b) consists of nitrite standard 
dissolved in and injected using mobile phase composed of 50 mM Acetate, 0.5 
mM TBAOH at a pH of 6.0.  In the bottom overlay, trace (c) is an applied potential 
of + 0.750 V, and trace (d) is an applied potential of + 1.0 V for amperometric 
detection of nitrite. 
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Figure 2.4:  UV chromatogram of nitrite and nitrate standards in Ringer’s solution.  
Standards (50 uM) are dissolved in Ringer’s Solution and injected using mobile 
phase of 100 mM acetate and 0.5 mM TBAOH at a pH of 6.0 with a flow rate of 
0.4 mL/min.  Standards were detected at 220 nm. 
 
0 1 2 3 4 5 6 7 8 9
5 mAU
Nitrate
Nitrite
UV: 220nm  50M Nitrite Nitrate in Ringer's Soln.
     MP: 100mM Acetate 0.5mM TBAOH pH: 6.0
time (min.)
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spinal fluid (aCSF) in preparation for microdialysis sampling in-vivo.   Figure 2.4 
shows this separation using UV detection, allowing for visualization of both nitrite 
and nitrate separation on the same chromatogram. 
   
2.3.3 Separation and detection optimization of nitrite and nitrate in basal   
microdialysis samples 
Dialysate samples from various sources were examined.  First, basal rat 
plasma dialysate samples were analyzed.  Nitrite and nitrate were identified by 
retention times in comparison to standards.  At this stage, the analysis of plasma 
dialysate samples was to test the method as a proof of concept to determine if 
analytes in dialysate could be detected.  The initial goal was to use this method to 
examine the presence of nitrite and nitrate in the brain, however microdialysis 
samples from a variety of tissues were available and worth examining.  
 
Prefrontal cortex, liver, and plasma dialysis samples were analyzed.  
Studying rat dialysate samples from the pre-frontal cortex of the brain and the 
plasma, as well as liver, as modifications of the method progressed brought up an 
interesting problem:  the co-elution of an electrochemically active compound with 
nitrite.  These chromatograms are shown in Figure 2.5.  The concentration of 
acetate was reduced to 75mM in order to retain the analytes longer on the column 
to increase separation between the interferent and nitrite.  In addition, the pH of 
the mobile phase was reduced to 4.0 to allow for complete resolution of the 
interferent from nitrite.  Under these new mobile phase conditions, dialysate from 
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the lumen of the large intestine and from the liver of a rat was analyzed.  
Separation between nitrate and the interferent was achieved; however, detection 
of nitrate in lumen dialysate proved difficult, as shown in Figure 2.6.   
 
UV detector wavelength changes were evaluated as well as that of the 
detector filter.  Closer to 205 nm, analyte signal response was high, but elevation 
in noise was significant.  On the other hand, noise was significantly lower closer to 
230 nm, but with a reduction in analyte signal.  The best signal to noise (S/N) was 
achieved at 220 nm.  Filter settings can be adjusted to remove high frequency 
noise by altering the time constant, improving S/N.  Setting the response to a 
lower value of less than 5 (1.5 sec) increases the response with a minimal 
increase in noise.  In addition, setting the response to a value of 6 or higher (3.0 
sec) reduces the response, but also substantially reduces noise [4].  Adjustments 
of filter settings were attempted, with selection of one providing the best S/N.  The 
optimal S/N setting was achieved by increasing the time constant of the filter from 
0.5 sec to 3.0 sec, achieved by changing the response from 3 to 6, respectively. 
 
The pursuit of animal studies demonstrated the need for a method capable 
of sub-µM limits of detection utilizing sample injection sizes below 5uL.  To 
minimize the sample size needed for analysis as well as reduce mobile phase 
required for analysis, the original 2x250 mm column was replaced with one of a 
smaller inner diameter and length with identical stationary phase (Phenomenex 
Synergi 4 µm Hydro-RP 80 Å, 1 mm x 150 mm).  A decrease in column diameter  
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Figure 2.5:  Chromatograms of rat plasma dialysate.  Mobile phase conditions are 
the same as shown in the previous figure.  Nitrite and nitrate are detected using 
+1.0 V as an applied potential (a) and 220 nm as a detection wavelength (b), 
respectively.  Note the presence of an electrochemically active interferent co-
eluting with nitrate.   
(a) 
(b) 
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increased mobile phase back pressure and required a decrease in flow rate from 
0.4 mL/min. to 0.1 mL/min.  Furthermore, the injection loop and corresponding 
injection volumes were reduced from 5 µL and 3 µL to that of 2 µL and 1 µL, 
respectively. Upon running standards through the new column under previous 
chromatographic conditions, inadequate separation of nitrite from an interferent, 
as well as the presence of significant background noise on nitrate 
chromatograms, was problematic.  A reduction in acetate concentration to 50 mM 
and an increase in the ion-pair reagent to 2.5 mM improved both separation and 
reduced noise.  From a reduction in column dimensions, it was possible to obtain 
an increase in nitrite and nitrate peak response by a factor of 4.  A reduction in 
injection volume by a factor of 3 resulted in a decrease in response by a factor of 
close to 3.   What this means is that taking into consideration both the change to 
the smaller column (increased response by 4) as well as a reduction in injection 
volume (decreasing the initial gain in response that resulted from switching to a 
small column by a factor of 3), that the change in peak response resulting from 
these modifications is approximately 1.5 times greater than that achieved with the 
larger column and injection loop.  A table showing these modifications as well as 
changes in peak response for nitrite is shown in Figure 2.7. 
 
The decision was made to change from an organic acid to an inorganic 
one.  The premise behind using another type of acid was to minimize background 
noise.  Acetate absorbs strongly in the UV region at less than 230 nm where 
analysis occurs.  Sulfuric acid was chosen as it does not absorb in the UV region 
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of analysis and after several concentration optimization experiments, was added 
at a concentration of 15 mM.  Subsequently, tetrabutylammonium hydroxide 
(TBAOH) was increased to 12 mM and the final pH set to 4.0.  A further increase 
in pH would increase the oxidation of nitrite, however resulted in reduced 
resolution between the analyte and other compounds.  Furthermore, due to a 
combination of a review of past hydrodynamic voltammograms and the change in 
mobile phase conditions, it was also decided to increase the applied potential 
from +1.0 V to +1.025 V.  The reasoning behind this increase is that it puts nitrite 
response in the middle of a plateau, such that any minor potential fluctuation will 
not affect response.  The final conditions were 12 mM TBAOH, 15 mM H2SO4, at 
pH: 4.0, with detection conditions at 220 nm for absorbance and an applied 
potential of +1.025 V vs. Ag/AgCl for amperometric detection. 
 
2.4 Method Validation 
All validation parameters were evaluated according to established good 
laboratory procedures [5].  These parameters were determined for nitrite and 
nitrate standards  in Ringer’s Solution and saline solution.   
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Figure 2.6:  Chromatograms of spiked rat large intestine lumen (probe implanted 
5 cm superior of rectum) dialysate.  Note that on the UV chromatogram, 
quantitation of nitrate is problematic.  Trace (a) is 5 cm lumen dialysate, trace (b) 
is 5 cm lumen dialysate with 2 µM nitrite spiked in, and trace (c) is 5 cm lumen 
dialysate spiked with 13 µM nitrite for the top UV overlay.  For the bottom EC 
overlay, trace (d) is 5 cm lumen dialysate, trace (e) 13 µM nitrate spiked in, and 
trace (f) is 2 µM nitrite spiked in.  Nitrite and nitrate were detected using the same 
applied potential and wavelength as in the previous figure.  Mobile phase 
conditions were comprised of 75 mM acetate, 0.5 mM TBAOH at a pH of 4.0.  
Detection conditions were 220 nm for UV-absorbance and an applied potential of 
+1.025 V vs. Ag/AgCl for amperometric detection 
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Column, Injection Loop, and Mobile Phase Modifications 
Column 
Phenomenex Synergi ® 
Hydro RP 2x250mm 4µm 
80Å 
Phenomenex Synergi ® 
Hydro RP 1x150mm 4µm 
80Å 
Mobile Phase 0.5 mM TBAOH, 75 mM 
acetate, pH: 4.0 
2.5 mM TBAOH, 50 mM 
acetate, pH: 4.0 
Flow Rate 0.4 mL/min. 0.1 mL/min. 
Injection Loop 
Volume 5 µL 2 µL 
Injection Volume 3 µL 1 µL 
Average Nitrite 
Response 6.97 nA 11.6 nA 
 
Figure 2.7:  Table comparing changes made in column, injection loop, and mobile 
phase and their influence on response of a 1µM nitrite standard injected. 
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2.4.1  Variability in Retention Times and Peak Areas 
The retention times of these compounds were examined through repetitive 
injections.  Intraday RSD values for nitrite and nitrate standards were calculated 
as 1.25% and 0.239% respectively, well below 5%.  Multiple injections of nitrite  
and nitrate standards were evalutated for peak areas.  RSD values for peak areas 
of nitrite and nitrate were 2.66% and 1.74%, respectively.   
 
2.4.2 Limits of Detection (LOD) and Quantitation (LOQ) 
The limits of detection for these compounds were established through the 
successive dilution and injection of nitrite and nitrate standards in aCSF, Ringer’s 
solution, and saline solution in those solutions, respectively.  For the analytes of 
nitrite and nitrate the limits of detection (S/N = 3) were 96 nM and 700 nM, 
respectively.  For the analytes nitrite and nitrate the lower limits of quantitation 
(S/N = 10) were 320 nM and 2.7 µM, respectively.  LOD and LOQ values were 
independent of the solution standards were dissolved in. 
 
2.4.3 Linear Range of Nitrite and Nitrate 
The linear ranges for nitrite and nitrate were established through the 
injection, separation, detection, and quantitation of nitrite standards present in 
aCSF, Ringer’s solution, and saline solution in concentrations from 320 nM to 
1000 µM.  Plots of response versus concentration were made for each analyte, 
with determined R2 values of 0.999.  Nitrite was determined to have a linear range 
of 320 nM-1000 µM.  The value of 320 mM is at the limit of quantitation for this 
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Figure 2.8:  Method validation parameters.  Nitrite was evaulated using 
amperometric detection at an applied potential of + 1.025 V.  Nitrate was 
evaluated using an absorbance wavelength of 220 nm.  Note the lower detection 
and quantitation limits allowed by amperometric detection of nitrite. 
micromolar levels than that of nitrite in basal dialysate, making UV-vis amenable 
for nitrate concentration change studies.  Figure 2.8 shows a table of the 
validation of these parameters. 
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analyte using the developed EC cell-based amperometric detection method.  
Nitrate was determined to have a linear range of 2.7-1000 µM.  The value of 2.7 
µM is at the limit of quantitation established by the development of the UV-Vis 
detection method.  The higher limit of quantitation of nitrate was due to higher 
limits of detection for this compound, a limitation of the UV-Vis detection system.  
However, nitrate was found to be present in higher concentrations of low 
micromolar levels than that of nitrite in basal dialysate, making UV-vis amenable 
for nitrate concentration change studies.  Figure 2.8 shows a table of the 
validation of these parameters. 
 
2.5 In vitro studies 
2.5.1  Introduction of Diethylamine (DEA) NONOate 
DEA NONOate is a member of the NONOate class of compounds.  What 
makes these compounds similar is that they are all composed of the general 
chemical formula R1R2N-(NO-)-N=O.  In this formula, R1 and R2 are alkyl groups 
and are the only differences in structure between the various NONOates.  These 
compounds act as NO donors when dissolved in aqueous solution, with a wide 
variety of literature supporting their study [6, 7, 8, 9].  The structure of 
diethylamine NONOate consists of two ethyl groups attached to a nitrogen 
attached to a NO- group and terminal nitrosyl group.  It is these adjacent NO 
containing groups which form two NO molecules upon decomposition [10]. 
The stability of these NO donors is pH dependent.  Below pH 8.0, DEA 
NONOate decomposes in a first-order process.  At pH 7.4 and temperature of 
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37°C, this compound has a half-life of 2 minutes.  In addition, one mole DEA 
NONOate releases 2 moles of NO upon decomposition [11].   
 
2.5.2  In vitro collection of NO from DEA NONOate sampling 
To evaluate the relative generation of NO and nitrate from DEA NONOate, 
an in vitro cell was used in which various concentrations of DEA NONOate was 
added.  The DEA NONOate (Cayman Chemical, Ann Arbor, MI) was made up in a 
vial in a 1mL volume at a concentration of 10mg/mL using Ringer’s solution 
containing 0.1M NaOH (Sigma, St. Louis, MO).  This stock solution was then 
diluted five-fold to 2 mg/mL or 1 mM using Ringer’s solution.  The probe was 
immersed in the cell containing the DEA NONOate standard made up in Ringer’s 
solution, stirred at a temperature of 37ºC, to mimic in vivo conditions as closely as 
possible.  A 1mL syringe containing aCSF was used to perfuse the probe at a flow 
rate of 1µL/min.  Dialysate was collected in microcentrifuge tubes at 10 minute 
intervals.  Collected samples were then analyzed using the LC-UV-EC system to 
determine the overall change in response reflective of concentration.  Upon 
completion of the 1 mM in vitro study, addition studies were conducted with 
100µM and 1 µM concentrations.  An overlay of two chromatograms of nitrite 
standard and a sampling from 100 minutes after the start of the 1 mM DEA 
NONOate introduction to the in vitro cell are shown in Figure 2.9.  It is clear that 
the peak resulting from the DEA NONOate sampling experiment is nitrite.  
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Figure 2.9:  Overlay of chromatograms from 1 mM DEA NONOate sample and 
100 µM nitrite Standard.  The peak from DEA NONOate administration is nitrite.  
Trace (a) is a 100 µM nitrite standard and trace (b) is nitrite produced from a 1 
mM DEA NONOate sample.  Mobile phase conditions are comprised of 12 mM 
TBAOH, 15 mM H2SO4, pH 4.0 at a flow rate of 0.1 mL/min.  Nitrite was detected 
using an applied potential of +1.025 V. 
(a) standard 
(b) sample 
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Figure 2.10:  Comparison of response and log response due to nitrite obtained 
from 3 DEA NONOate concentrations in in vitro studies during time course 
experiments after 60 minutes of basal collection.  DEA NONOate concentrations 
of 1µM, 100uM, and 1mM were used in these experiments.  The bottom diamond 
plot is 1 µM DEA NONOate, the middle square plot is 100 µM DEA NONOate, 
and the top triangle plot is 1 mM DEA NONOate.  Mobile phase conditions are the 
same as in the previous figure.  Nitrite detection parameters are the same as 
previously established.  
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Additionally, experimental graphs of response for nitrite versus time for the 3 
concentrations used in the experiments are shown in Figure 2.10.  Similar DEA 
NONOate studies have been conducted by the S. Lunte research group and 
showed similar results [6]. 
 
2.6  Microdialysis probe calibration 
 
To evaluate the relative recovery of nitrite and nitrate based upon probe 
type and flow rate used for experiments, an in vitro microdialysis cell was used in 
which nitrite and nitrate standards were added.   A 1mL syringe containing aCSF 
was used to perfuse the probe at a flow rate of 1µL/min.  Dialysate was collected 
in microcentrifuge tubes at 10 minute intervals.  Collected samples were then 
analyzed using the LC-UV-EC system to determine their concentrations.  This 
experiment served to monitor recovery of these analytes to compensate for 
resistance to analyte diffusion from the sampling environment to the internal 
portion of the probe as dialysate. 
 
The process of recovery is composed of several steps where compound of 
interest first moves through the tissue present in the proximal environment.  When 
the compound encounters the microdialysis membrane, it then diffuses due to the 
presence of an osmotic gradient.  In other words, the concentration of the analyte 
in the surrounding medium is greater than that in the perfusate, so the analyte will 
cross the membrane to establish an equal concentration on both sides.  Finally, 
once present in the dialysate the analyte freely diffuses.   
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Figure 2.11:  In vitro cell setup with analyte stirred and maintained at 
physiological temperature.  Artificial cerebrospinal fluid (aSCF) is perfused 
through the probe and analyte is collected as dialysate. 
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Achievement of a steady-state concentration prior to a decline in concentration in 
the sampling vessel was used to determine analyte recovery.  A simplified 
equation shown in the first chapter ( R =

Cdial.
Csample
x100%) was used as a good 
determinant of analyte recovery.  The steady-state concentration found was 
divided by the known concentration in the cell and multiplied by 100 to give the 
relative recovery of each analyte.  The relative recoveries for nitrite and nitrate 
were found to be 49.3  0.6%  and 37 1% , respectively.  Figure 2.11 shows the 
in vitro cell setup. 
 
 
2.7   Analysis of microdialysis samples 
 
Upon development of ideal separation conditions for nitrite and nitrate 
standards, microdialysis samples collected under basal conditions in rats were 
analyzed.  Two regions were examined in the final stage of method development.  
Dialysate collected from the mucosal region of the large intestine and that of the 
hippocampus region of the brain were studied.  To identify peaks, all samples 
were spiked with nitrite and nitrate standards.  All samples were injected into the 
chromatographic system and analyzed by UV and EC detection.  Resulting 
chromatograms are shown in Figures 2.12 and 2.13. 
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Figure 2.12:  Rat intestine 5 cm submucosa (probe 5 cm superior to the rectum) 
dialysate samples spiked with nitrite and nitrate standards.  In the top overlay, 
trace (a) is 5 cm submucosa, trace (b) is 5 cm submucosa spiked with 1 µM 
nitrite, and trace (c) showing an increased response for nitrite is 5 cm submucosa 
with 13 µM nitrite spiked in for the top UV overlay.  The bottom overlay, trace (d) 
is 5 cm submucosa, trace (e) is 5 cm submucosa spiked with 1µM nitrite, and 
trace (f) is 5 cm submucosa with 13 µM nitrite spiked in.  Mobile phase conditions 
consist of 12 mM TBAOH and 15 mM H2SO4 at a pH of 4.0.  Mobile phase flow 
rate was 0.1 mL/min.  Nitrite and nitrate are detected using the same parameters 
as previously established.  
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Figure 2.13:  Basal rat brain hippocampus dialysate samples spiked with nitrite 
and nitrate standards.  Trace (a) is basal dialysate and trace (b) is basal dialysate 
spiked with 10 µM nitrate for the top UV overlay.   Trace (a) trace is basal 
dialysate and trace (b) is basal dialysate spiked with 1 µM nitrite for the bottom EC 
overlay.  Mobile phase and detection conditions are the same as described in the 
previous figure. 
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2.8  Summary 
An LC-based UV-EC system was developed through the optimization of 
multiple parameters.  Examining changes in applied potential and absorbance 
wavelength and their effects upon analyte response and background noise made 
it possible to select detection parameters to make analyte identification at 
concentrations seen in basal dialysate samples possible.  Chromatographic 
separative conditions were optimized to separate nitrite and nitrate.  In addition, 
this method was validated for variability in retention times and peak areas, limits 
of detection and quantitation, and linear ranges of the analytes studied.  Also, in 
vitro studies were pursued to demonstrate that this method was capable of 
detecting and quantifying stable secondary products resulting from RNS 
formation.  Upon completion of these studies, nitrite and nitrate were separated 
from other compounds present in basal dialysate samples.     
    
Microdialysis probes were calibrated through nitrite and nitrate recovery 
studies under in vitro conditions designed to mimic the rat brain environment as 
closely as possible.  Through the determination of recoveries of these 
compounds, it is possible to then compensate and calculate for the true analyte 
concentrations as they would be in the rat brain environment. Upon completion of 
these experiments, it was possible to move on to the final stages of 
chromatographic as well as UV-Vis and EC method development.  Upon 
completion of development of this method, it was possible to move on to animal 
studies.  
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3   Animal methods and 3-MPA rat microdialysis studies 
 
3.1  Introduction 
 
The 3-MPA rat model was previously developed in this research group to 
monitor changes in the levels of the neurotransmitters glutamate and GABA, with 
the goal of facilitating a greater understanding of cellular biochemical changes 
caused by induced seizures  [1]. Previous studies using this model have shown 
that under 3-MPA-induced oxidative stress conditions, biomarkers such as the 
neurotransmitters glutamate and GABA (Mayer thesis) and lipid peroxidate 
malondialdehyde (Cooley thesis) are produced at elevated concentrations.  
However, nitric oxide production under these oxidative stress conditions has not 
been evaluated.  Nitric oxide is biomolecule of interest for this thesis; however, it 
is very labile and must be measured though the analysis of stable secondary 
products [2, 3].  
 
3.2  Objectives 
 
Formation of RNS and their contribution to oxdative stress had not been 
evaluated in the 3-MPA rat model.  The primary goal of these studies was to use 
the methods discussed in the previous chapter to study RNS generation in the rat 
brain as a result of 3-MPA infusion.  Data gathered from these experiments would 
complement previous studies monitoring changes in glutamate and GABA levels, 
as well as lipid peroxide formation.  A multiple biomarker evaluation will offer 
greater insight into the biochemical pathways involved, and from that, a greater 
understanding of oxidative stress.   Brain surgeries were conducted in rats to 
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create pharmacologic induction of oxidative stress and to measure changes in 
nitrite, the biomarker of nitric oxide production.  From monitoring of nitrite levels, it 
was possible to determine if RNS generation was one factor contributing to 
oxidative stress and the associated cellular damage.   
 
3.3   Animal Methods 
3.3.1   Surgical procedure for microdialysis sampling 
 
All animal experiments were conducted in accordance with Institutional 
Animal Care and Use Committee (IACUC) animal use procedures.  Male Wistar 
rats in the body mass range of 200-225g were used for all surgeries.  Rats were 
placed under anesthesia via induction with isoflurane inhalation followed by 
subcutaneous injection of a mixture containing acepromazine (0.67mg/kg), 
ketamine (67.5mg/kg) and xylazine (3.4mg/kg).  Body temperature was regulated 
using a rectal temperature probe interfaced with a temperature controlled heating 
pad.  To prepare the animal for surgical incision, the cranial area from the upper 
region of the neck to the front of the eyes was clipped of hair.  In addition, the 
eyes were covered with Surgilube®, a protective bacteriostatic lubricant to prevent 
drying (Fougera Pharmaceuticals, Melville, NY).    
 
The animal was placed into a stereotaxic frame, and the skull was pinned 
just prior to the auricular canal.  An example is shown and coordinate system of 
the stereotax used in these surgeries is described in Figure 3.1.   
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Figure 3.1:  Stereotax showing A/P, M/L, and D/V coordinates for accurate and 
precise marking and skull penetration for brain surgeries.  In addition, note 
locations of auricular pins and jaw holder for cranial immobilization and holder for 
cannula implantation.  Reproduced with permission from Bilaney Consultants.  
A 
P 
D 
V 
M L 
Jaw Holder 
Cannula Holder 
Auricular Pin 
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Upon positioning of the skull, the site of incision was scrubbed with iodine 
and isopropyl alcohol alternatingly and allowed to dry.  An incision was made 
using a #10 blade in the medial position, running in the anterior position from the 
brow posteriorly to the occipital process.  Four bulldog clips were used to retract 
the skin and underlying tissue from the incision site, revealing the skull.  A cotton-
tipped applicator was dipped in syringe filter sterilized saline and used to brush 
away the adventitial membrane covering the skull at the site.  A cannula was 
placed into the stereotaxic armature and lowered into position at the intersection 
of the frontal and parietal bones, known as the bregma.  This intersection served 
as a zero point and was marked with a surgical pen.  Stereotaxic coordinates of  
-3.3 (A/P), +1.7 (M/L), and -2.7 (D/V) were used to mark the position for cannula 
and probe insertion.   
 
To facilitate stable cannulation, one small mark was made several 
millimeters medial to the probe implantation site.  Holes were drilled at the probe 
implantation site and medial site using a hand powered drill bit holder, using 1 and 
2 millimeter bits.   A guide cannula and bone screw was implanted at the 
stereotaxic coordinate and medial holes, respectively.  The purpose of the bone 
screw was to serve as an anchor point for the dental acrylic necessary for cannula 
fixation.  The dental acrylic was applied on the skull around the cannula and bone 
screw, with special care to ensure the cement covered the external portion of the 
cannula.   
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Upon incision closure around the probe, a microdialysis probe (CMA 20, 
Solna, Sweden) was inserted into the guide cannula and seated.  The 
microdialysis probe inlet and outlet were composed of FEP tubing.  The probe 
inlet was then connected to a 1mL syringe (Hamilton, Reno, NV) containing aCSF 
and perfused at a flow rate of 1uL/min.  The aCSF was comprised of calcium 
chloride (1.2 mM), magnesium chloride (1.0 mM), potassium chloride (2.7 mM), 
sodium chloride (145 mM), sodium phosphate monobasic (0.45 mM), and sodium 
phosphate dibasic (2.33 mM).  The probe was initially allowed to perfuse for an 
hour, or about the time required for surgical cannula implantation.  Upon 
completion of the probe implantation and before basal collection, the probe was 
allowed to perfuse for an hour to flush for recovery.  Samples were collected into 
microcentrifuge tubes for a duration of 10 minutes each. 
 
3.3.2  Microdialysis Sample Collection 
All microdialysis probes were perfused with Ringers solution for initial DEA 
NONOate studies.  For rat hippocampus studies, aCSF was perfused at a flow 
rate of 1µL/min for the duration of the implantation procedure.  Upon insertion of 
the probe into the sampling site, flushing was allowed to occur for 1 hour at 
1µL/min into a microcentrifuge tube inserted into a vacant location of a vial holder.  
The flushed solution as one large volume was collected for analysis over this 
period.  After the hour-long waiting period, a new microcentrifuge tube was 
inserted into the vial holder and dialysate was collected for 10 minutes.  Following 
this period, the vial was switched with an empty one and the 10 minute collection 
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time was repeated.  This process was repeated for approximately one hour as 
basal collection.  The syringe containing Ringers or saline was then switched with 
that containing a known concentration of the pharmacological agent of study.  
Dialysate was then collected at 10 minute intervals for the remainder of time 
dictated for the agent perfusion.  After the administration period, the syringe 
containing the pharmacological agent (3-MPA) was switched with that of Ringers 
or saline and that perfusate was delivered for the remainder of the experiment.  All 
microcentrifuge tubes collected were immediately frozen at -20ºC before being 
transferred to a -80ºC freezer if they were not to be analyzed at the time of the 
animal experiment.  Analyte concentrations were stable for several months upon 
storage in the -80ºC freezer. 
 
3.3.3  Microdialysis Sample Injection 
 
Following sample thawing, all samples were vortexed (Barnstead 
International, Dubuque, IA).  Samples were divided in two, with one half going 
toward analysis using the methods described in this thesis, and the other going 
toward another group member’s research.  A Shimadzu LC-20AD pump was used 
to pump mobile phase (60: 40, acetonitrile: H2O) to the Rheodyne ® 7725i 
injector.  Standards were pulled up into the barrel of an injection syringe 
(Hamilton, Reno, NV) at the 1µL mark and the syringe needle was inserted into 
the injector port.  The contents of the syringe barrel were then pushed into the 
2µL injection loop and the injection valve was turned to inject the sample.  
Injected samples were separated chromatographically using a Phenomenex ® 
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Synergi Hydro-RP 4µ 80Ǻ and detected using Shimadzu SPD-10AV ultraviolet 
and Bioanalytical Systems LC-4C amperometric detection systems in series as 
described in chapter 2.  
 
3.4 Initial Rat Studies Results 
 
3.4.1  3-MPA study 
 
3-MPA is a chemical whose use has been extensively investigated in this 
research group.  The compound has been specifically used to induce neuronal 
damage resulting from oxidative stress.  3-MPA accomplishes this via the 
inhibition of glutamate decarboxylase (GAD) [4].  The enzyme is responsible for 
the conversion of the excitatory amino acid glutamate into an inhibitory amino acid 
γ-aminobutyric acid (GABA), keeping neuronal firing in balance.  As a result of 
inhibition of this enzyme, an increase in glutamate occurs, with a reduction in 
GABA, leading to neuronal hyper-excitation [5, 6].  Furthermore, glutamate acts 
upon several ionotropic and metabotropic neuronal cell membrane receptors 
responsible for calcium influx.   
 
Upregulation of N-methyl-D-aspartate (NMDA), kainate, and  α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors leads to a cellular 
influx of Ca2+.  In addition, glutamate activates the metabotropic glutamate 
receptors (mGluRs), which in turn activate additional ionotropic receptors.  An 
intracellular influx of Ca2+ results in nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase and cyclooxygenase (COX) activation and the generation of 
superoxide anion.  Previous studies investigated the change in concentrations of 
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the glutamate and GABA, as well as the formation of lipid peroxides (Crick thesis, 
Mayer thesis, Cooley thesis).   
 
Research conducted in this group has found that both glutamate and 
GABA increase in a dose dependent manner after direct 3-MPA administration 
(Meyer thesis).  One explanation of the increase in GABA is that it is a result of an 
inhibitory surround, a self-preservation mechanism where surrounding neurons 
secrete GABA in an attempt to get affected cell hyperexcitation under control and 
minimize damage [7].  It has also been shown that free lipids such as arachidonic 
acid are attacked by superoxide and converted to bicyclic endoperoxides 8].  
These compounds are further degraded to 4-hydroxynonenal, acrolein, and 
malondialdehyde (MDA).  A method has been developed in our group to detect 
and quantify MDA.  Increases in the production of MDA in a dose-related manner 
have been observed (Cooley thesis).  This finding most likely suggests that 
superoxide is generated at levels proportional to NADPH oxidase and COX 
upregulation as a result of administered 3-MPA concentrations [9, 10].   
 
Studies of RNS formation as a result of 3-MPA administration were 
conducted as part of this thesis.  Results of these studies have been rather 
surprising, as no increase in nitrite formation from RNS production as a result of 
3-MPA administration was found.  This finding could be due to several reasons.  
The first is that RNS production is dependent upon a large Ca2+ influx necessary 
for eNOS and nNOS activation.  It is very possible that the increased production 
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of glutamate from 3-MPA administration has a limited effect on ionotropic 
glutamate receptors.  This shortcoming could also be due to the use of ketamine 
as an anesthesia of choice.   
 
Ketamine is known to antagonize the ionotropic glutamate receptors NMDA 
and AMPA.  From reduced NMDA and AMPA activity, a reduction in Ca2+ 
intracellular influx may occur, reducing the amount of Ca2+ available for eNOS and 
nNOS activation.  In an alternate hypothesis, multiple steps required for NOS 
activation and NO formation from 3-MPA administration to eNOS/nNOS 
upregulation and the limited efficiency of each step may reduce the concentration 
of Ca2+ available for eNOS/nNOS upregulation, resulting in little production of NO.   
 
It was originally postulated that NO was generated at elevated levels, but 
remained peroxynitrite for an extended period of time such that conversion to 
nitrite was minimal.  However, in vitro experiments with the NO donor DEA 
NONOate showed that under conditions similar to those encountered 
physiologically, NO was rapidly converted to nitrite.  Nitrate was not seen under in 
vitro conditions. 
 
3.4.2  Initial Study of 3-MPA Standards 
 Prior to the pursuit of 3-MPA microdialysis studies in rats, a 3-MPA 
standard was injected to confirm that no peaks interfered with nitrite.  The delivery 
of 3-MPA was previously determined in this research group (Crick thesis) to be 
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about 90%, independent of analyte concentration.  From experiments of 10 mM 3-
MPA infusion, it was assumed that about 90% of the 3-MPA was delivered by the 
microdialysis probe.   
 
As the result of a 1 mM 3-MPA injection, no peak close to the limit of 
quantitation of nitrite was visible.  However, with the injection of 10 mM 3-MPA 
standards, a peak co-eluted at a response significantly above that of a 10 µM 
nitrite standard.  Furthermore, in another experiment 3-MPA was spiked with 
nitrite.  Retention times of peaks present in the chromatograms from this 
experiment were compared with those of peaks of individual 3-MPA and nitrite 
standards.  The retention times essentially matched for nitrite in nitrite standards 
and a peak present in 3-MPA standards, with times of 5.6 and 5.9 min, 
respectively.  This interference was not 3-MPA itself, which eluted at 17 min., but 
an unknown contaminant in the 3-MPA solution.  Chromatograms comparing the 
retention times of these various peaks are shown in Figures 3.2 and 3.3.  It 
became necessary to modify the mobile phase conditions to resolve the 
interferent in 3-MPA from nitrite and allow 3-MPA rat studies to commence.  
Mistaking an interferent of the pharmacological agent being dosed for nitrite would 
be disastrous if animal studies were conducted and would undermine the project.  
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Figure 3.2:  Overlay of various EC chromatograms evaluating the contribution of 
3-MPA as an interferent with nitrite.  Injection of 10 mM 3-MPA solution is 
significant in that an interferent with nitrite is present in levels giving a response 
greater than the limit of quantitation for nitrite.  In addition, the response is 
significantly above nitrite generated under basal conditions in the rat 
hippocampus.  At a 1mM concentration, 3-MPA solution doesn’t contribute a 
significant interferent. Trace (a) is 1 mM 3-MPA, trace (b) is 10 µM nitrite, trace (c) 
is under basal conditions, and trace (d) is 10 mM 3-MPA.  Mobile phase and 
detection conditions were identical to the last figure in the previous chapter.  
 
12 mM TBAOH 
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Figure 3.3:  Comparison of EC chromatograms of a 3-MPA solution, a 3-MPA 
and nitrite mixture, and a nitrite standard.  Note complete co-elution of the 
interferent and nitrite in the mixture, problematic for identification and quantitation 
of nitrite in dialysate.  Trace (a) is 12 µM nitrite + interferent present in 5 µM 3-
MPA, trace (b) is interferent present in 10 mM 3-MPA, and trace (c) is 25 µM 
nitrite.  Detection and mobile phase conditions are the same as that of earlier 
figures in this chapter.   
 
12 mM TBAOH 
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3.4.3  Mobile Phase Condition Modification for Interferent-Nitrite Resolution 
 Upon detection of this interferent, it was deemed necessary to modify 
mobile phase conditions in order to separate the previously identified interferent 
from nitrite and minimize the likelihood of problems in the future when using 3-
MPA solutions.  Alterations in pH and sulfuric acid concentrations would be 
problematic, as they would affect the detection characteristics of nitrite as well as 
the separation.  Altering pH would affect retention times of nitrite and the 
interferent.  Altering the concentration of the ion-pairing agent TBAOH seemed 
like the most logical approach to increasing the resolution between nitrite and the 
interferent.  After making any change in the ion-pairing agent concentration, the 
mobile phase was run through the column for a 24 hour period to allow for 
equilibration, ensuring constant retention times for analytes.  
 
The concentration of TBAOH was reduced from 12mM to 4 mM.  This 
change resulted in the merging of nitrite and the 3-MPA artifact such that they 
were indistinguishable from one another (not shown).  Reducing from 12 mM to 4 
mM did not significantly improve the separation stems from the likelihood that 
excess ion-pairing reagent was present in amounts far greater than needed to 
saturate the stationary phase surface octadecyl groups.  Any increase in ion-
pairing agent beyond this saturation point does not increase analyte retention 
time.   
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Figure 3.4:  Comparison of nitrite standard with a rat hippocampus microdialysis 
sample at the height of 3-MPA administration.  Note that the peak which 
corresponds with nitrite in the microdialysis sample is nonexistent, while that of 
the artifact at 4 minutes is prominent, a feature previously mistakenly identified as 
nitrite.  Trace (a) is 5 µM nitrite and trace (b) is 50 minutes after 10 mM 3-MPA 
dosing. Detection conditions are unchanged.  Mobile phase conditions are 1 mM 
TBAOH and 15 mM H2SO4 at pH 4.0. 
 
1 mM TBAOH 
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Upon this finding, TBAOH was further reduced to 1 mM and showed an 
improvement in the resolution between the interferent and nitrite. The separation 
was improved because the stationary phase was likely at a saturated or under-
saturated point.  At a saturated point, maximum interaction of the analyte with the 
charged head groups of the ion-pair reagent occurs.  Furthermore, at an under-
saturated point, ion-pair charged head groups are able to interact with analyte 
whilst adsorbed to the stationary phase, in addition to the greater likelihood of the 
hydrophobic octadecyl groups of the stationary phase interacting with analyte as 
well.   
 
To potentially improve the separation further from its current state, it was 
decided to decrease TBAOH to 0.5 mM to determine if any positive change in 
resolution could be achieved.  The resolution was decreased as a result of this 
reduction to 0.5 mM; therefore, the TBAOH concentration was increased to 1 mM 
as the final modification.  In addition, dead volume associated with the 
chromatographic system was reduced.  Chromatographic tubing was cut to 
minimize the distance from the column outlet to the electrochemical cell of the 
detection system.  This reduction in dead-volume made it possible to minimize 
band-broadening and increase resolution between nitrite and 3-MPA interferent 
peaks.   Complete resolution between nitrite and the interferent was realized, as 
shown in Figure 3.4.  This was confirmed by spiking as well with nitrite, shown in 
Figure 3.5.  From these experiments, the final mobile phase consisted of 1 mM 
tetrabutylammonium hydroxide and 15 mM H2SO4, at pH 4.0.  Final equipment 
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and conditions for the method developed to detect and quantify nitrite are shown 
in Figure 3.6. 
 
3.4.4 Evaluation of nitric oxide product formation 
It was observed from early basal injections that nitrite was generated in rat 
brains implanted with microdialysis probes and perfused with Ringer’s or aCSF.  
Slight tissue trauma from probe implantation is common and leads to nitric oxide 
production from calcium influx due to probe-adjacent cyto-membrane damage and 
subsequent upregulation of NOS by Ca2+ [11,12].  UV and EC detection 
chromatograms showed the presence of RNS products nitrite and nitrate in basal 
dialysate samples.  Nitrite production as a result of this early nitric oxide formation 
is shown in Figure 3.7.  In this figure, nitrite production decreases from 
concentrations of close to 4µM to those below the limit of quantitation.  Upon 
dosing with 3-MPA, no increase of nitrite was found to have occurred.  Figure 3.8 
shows chromatograms from a rat experiment in which basal nitrite was below 
limits of detection, in comparison with dosing of 10 mM 3-MPA in which no 
increase in nitrite is observed.  A 10 µM nitrite standard is in the overlay to confirm 
that an increase in nitrite production is not occurring. 
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Figure 3.5:  Spiking of a rat hippocampus microdialysis sample at the height of 3-
MPA administration with nitrite standard.  The growth of a peak at 3 minutes is 
confirmatory of the separation between nitrite and the 3-MPA artifact.  Trace (a) is 
50 minutes after dosing and trace (b) is 50 minutes after dosing + 2 µM nitrite 
spike.  Detection and mobile phase conditions are the same as that of the 
previous figure. 
 
 
1 mM TBAOH 
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Figure 3.6:  Summarization of the final equipment used and conditions developed 
for the detection and quantitation of nitrite. 
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Figure 3.7:  Time course nitrite graph of a rat experiment in which the initial 60 
minute period is basal collection, followed by 50 minutes of 10 mM 3-MPA 
infusion.  An initial concentration of nearly 4 µM is present due to initial trauma 
due to probe implantation.  After 50 minutes of 10 mM 3-MPA dosing, nitrite 
concentration falls to below the limit of detection. 
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Figure 3.8:  Overlay of basal and 3-MPA dosed rat hippocampus dialysate 
samples.   In addition, a 10 µM nitrite standard is shown in the overlay to confirm 
that 3-MPA administration does not upregulate nitrite production.  This means that 
an increase in RNS does not occur as a result of 3-MPA administration.  Trace (a) 
is basal dialysate, trace (b) is 50 minutes after dosing, and trace (c) is 10 µM 
nitrite.  Mobile phase and detection conditions are the same as that of the 
previous figure. 
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3.5   Summary 
 Surgeries were performed to implant probes for microdialysate collection in 
the brain of rats.  From these procedures, it was possible to deliver pharmacologic 
agents into the brain as well as collect dialysate to monitor key endogenous 
compounds nitrite and nitrate in the future.  The initial goal of these surgeries 
were to collect dialysate necessary to support the development of 
chromatographic separation as well as UV-Vis and EC detection methods 
Furthermore, these surgeries made it possible to continue further animal studies.   
 
 In this chapter, research was conducted to determine whether or not 
damage occurring in the brain of the rat as a result of 3-MPA administration was 
influenced by RNS formation and activity.  In subsequent experiments, 
chromatographic conditions were further optimized to separate an artifact of 3-
MPA co-eluting with nitrite.  Maximization of resolution between these compounds 
was achieved with the promise of a return to animal experiments.  Upon 
separation of these compounds, it was determined that 3-MPA does not 
significantly increase nitric oxide production, and therefore, does not increase 
other RNS formation.  In conclusion, oxidative stress resulting from 3-MPA dosing 
is not influenced by RNS.   
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4.  Sheep Studies 
4.1  Introduction 
The ultimate goal of these studies was to develop an on-animal sensor for 
nitric or NO production.  Nitrite is the major product of NO metabolism.  
Collaboration with the S. Lunte research group evaluated the formation of nitrite 
from NO in sheep and rats administered various pharmacological agents including 
nitroglycerin and histamine.  Until 1977, the mechanism of nitroglycerin 
contributing to vasodilatation was unknown [1].  In 2002, it was found that 
nitroglycerin releases NO through reduction by the mitochondrial enzyme 
aldehyde dehydrogenase [2, 3].  This method of bioactivation is of incredible 
interest due to wide application of nitroglycerin as a vasodilator and in the 
treatment of heart attacks [2, 3].  In addition, in vivo histamine production or 
administration has been linked to nitric oxide production, generating the 
vasodilatation observed in inflamed tissues [4].  In addition, the reactive nitrogen 
species, such as peroxynitrite, generated in these inflamed tissues through the 
reaction of NO and superoxide is of interest.  The generation of nitrite as a 
biomarker of oxidative stress may help to explain cellular damage, which occurs 
upon these species’ formation.     
 
4.2 Objectives 
The primary goal of this research was to use nitroglycerin and histamine to 
generate NO and hence nitrite in skin tissue to evaluate an on-animal separation 
based sensor.  The formation of nitrite from administration of these compounds 
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meant vasodilatation was occurring in the tissue and that there was potential for 
RNS formation as well.  In addition, working in collaboration with the S. Lunte 
research group studying this biomarker of nitric oxide production made it possible 
to evaluate the versatility of the developed analytical methods in this thesis for 
nitrite in multiple animal models.   In particular, collaboration allowed for a direct 
comparison of the developed analytical method with microchip based methods for 
nitrite developed by the S. Lunte research group.  This group has developed a 
microfluidic device capable of sampling, separation, and amperometric detection 
of nitrite in sheep, known as ‘Lab on a Sheep’, through collaboration with Pinnacle 
Technologies, a company responsible for the construction of the circuit board and 
supporting electronics necessary for the chip to operate.  Through the comparison 
of the conventional and microchip methods, it was possible to use the method 
developed in this thesis to validate the ‘LOS’-Pinnacle Board method in use by the 
S. Lunte research group.  Furthermore, an LC-UV method was modified to identify 
and quantify nitroglycerin in solutions isoosmotic with respect to interstitial fluid 
encountered in sheep studies.  This method was used to determine the delivery of 
nitroglycerin through a microdialysis probe in in vitro experiments.   
 
 
 
4.3  Sheep nitroglycerin and histamine models 
Sheep have long been established as models for research studies.  
Microdialysis sampling has been used in sheep to monitor the pharmacokinetics 
of drugs and the metabolism of various biomolecules [5].  The S. Lunte research 
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group previously used sheep subcutaneous microdialysis probe implantation to 
evaluate the production of nitrite from nitroglycerin dosing [6].  In addition, this 
same research group has described a goal to study nitrite production as a product 
of histamine administration using microdialysis.   
 
4.4  LC-UV method modification for nitroglycerin detection 
4.4.1  Introduction 
A chromatographic method for nitroglycerin was developed to support in 
vitro studies was accomplished by injection, separation by a C-18 column using 
an acetonitrile and water mixture as mobile phase, and detection using a UV-Vis 
absorbance detector previously mentioned in this thesis at a wavelength of 210 
nm.  The separation and detection conditions were modified from those of Ahmad 
and colleagues [7], with the principle difference being the chromatographic 
column (Agilent ® Eclipse XDB 5µm 4.6x150 mm C-18), injection valve, and 
injection volume used by that group.   
 
4.4.2  Separation equipment specifications and mobile phase conditions 
The developed method used a Phenomenex ® Synergi Hydro-RP 4µm 80Ǻ  
2x150 mm C-18 column.  In contrast to the smaller dimension column used in 
previous chapters for the separation of nitrite and nitrate, this column was 
sufficient for analysis of nitroglycerin as large volumes of concentrated 
nitroglycerin samples were to be used.  The column used for nitroglycerin analysis 
in this thesis had polar endcapping on the stationary phase silanol groups.  This 
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modification provides greater stationary phase stability when exposed to aqueous 
mobile phase and greater interaction of polar analytes with the C-18 groups.  
Furthermore, the smaller 4µm particle size allows for greater resolution of peaks, 
which is beneficial when analyzing in vivo microdialysis samples in future studies 
[8].  The pump used was a Shimadzu ® LC-20AD operating at a flow rate of 0.4 
mL/min. and the mobile phase consisted of 60: 40 acetonitrile: water, which was 
ideal for separation of nitroglycerin from the void peak.  Nitroglycerin is 
hydrophobic enough to have strong interactions with the stationary phase C-18 
groups when present in aqueous mobile phase.  The presence of acetonitrile as 
an organic modifier serves to reduce the interactions of nitroglycerin with the 
stationary phase to an extent that analyte is eluted in a sharp peak at about 3 
minutes, which is ideal for obtaining the lowest possible limits of detection and 
quantitation.  Figure 4.1 shows the elution of nitroglycerin.  The injection valve 
used was identical to that used in previous chapters of this thesis, a Rheodyne ® 
7725i, with an injection loop volume of 2µL, using an 8µL overfill for injection.  All 
nitroglycerin solutions used for these and animal studies were prepared from a 5 
mg/mL stock solution containing ethanol (30%) and polyethylene glycol (30%) 
(American Regent, Inc., Shirley, NY).  
 
4.4.3  Detection conditions optimization 
       Detection conditions were modified from those established by Ahmad and 
colleagues [7], to be amenable to nitroglycerin analysis using the Shimadzu SPD-
10AV UV-Vis detector used in previous chapters of this thesis.  The method used 
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an absorbance wavelength of 210 nm [7].  The linear range of the method was 1-
1000 µM.  Final equipment and conditions for the method used to detect and 
quantify nitroglycerin are shown in Figure 4.2. 
   
4.5   Nitroglycerin in vitro delivery study 
Nitroglycerin delivery through a microdialysis probe was evaluated to 
determine its delivery into tissue in animal studies.  The experiment is set up in 
much the same way as that of DEA NONOate perfusion in chapter 2, except the 
solution was unstirred.  Nitroglycerin (5mg/mL) dissolved in ethanol (30%) and 
polyethylene glycol (30%) was loaded into a syringe (CMA 106, CMA 
Microdialysis, Solna, Sweden).   The syringe was loaded into a syringe pump 
(CMA 107, CMA Microdialysis, Solna, Sweden) and connected to tubing bonded 
to a 1 cm linear microdialysis probe with a polyacrylonitrile (30 kDa cutoff) 
membrane (MF-7049, Bionanalytical Systems Inc.).  The membrane was inserted 
into an in vitro cell containing 500 µL of Ringer’s solution and the connecting 
tubing was taped at the top of the cell to maintain probe position.  The flow rate of 
the nitroglycerin containing perfusate was set at 1 µL/min.   
 
Nitroglycerin was allowed to perfuse for approximately 8 hours to ensure 
adequate delivery of this compound into the vial.  At the end of this period, a 
sample of the solution in the vial containing the microdialysis probe was collected, 
diluted, and analyzed. 
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Figure 4.1:  Overlay of UV chromatograms of 100 µM nitroglycerin (b) and saline 
solution (a).  Mobile phase consists of acetonitrile: water, 60: 40.  Absorbance 
detection is at 210 nm. 
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Figure 4.2:  Summarization of the final equipment used and conditions modified 
for the detection and quantitation of nitroglycerin. 
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After 3 injections for each sample, responses generated from each injection were 
compiled and averaged.  The average response generated by the sample 
collected was converted to a concentration by the use of a nitroglycerin calibration 
curve (1-000 µM) compiled during the sample analysis period.  Nitroglycerin 
obtained from the vial was diluted by a factor of 20 prior to analysis to ensure it 
was in the linear range of the calibration curve and analyzed.  Nitroglycerin 
perfusate (5mg/mL) from the syringe was diluted by a factor of 40 to ensure that it 
was in the linear range of the calibration curve.  To compensate for the dilution 
factor, the concentration determined by each sample was then multiplied by that 
factor.  Analyte delivery was determined by the equation R =

Csample
Cperfusate
x100%
. 
Nitroglycerin relative delivery was calculated by dividing the steady-state 
concentration of this analyte in the sample measured from the vial at the end of 8 
hours by the known concentration in the perfusate and multiplied by 100. The 
relative delivery for nitroglycerin was found to be 10.6 1.2%. 
 
4.6  Initial study of histamine and nitroglycerin standards 
Prior to the pursuit of sheep studies, histamine and nitroglycerin standards 
were injected into the LC-EC system to determine if there was any interference 
with nitrite.   Histamine was injected at concentrations up to 1 mM without 
interferents.  Injection of nitroglycerin above 2.5 mg/mL concentrations in saline 
resulted in a peak which co-eluted with nitrite.  Figure 4.3 shows an overlay of the  
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Figure 4.3:  Overlay of co-elution of a compound present in nitroglycerin solution 
(2.5 mg/mL) (a) with a 5 µM nitrite standard (b).  Presence of ethanol (15%) and 
propylene glycol (15%) in the nitroglycerin solution (a) has shifted the retention 
time of the co-eluent in.  Detection was accomplished using an applied potential of 
+1.025 V.  Mobile phase conditions are 1 mM TBAOH and 15 mM H2SO4 at pH 
4.0. 
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Figure 4.4:  Overlay of 2 mg/mL nitroglycerin sample (a) (spiked with a 1 µM 
nitrite standard) with a 5 µM nitrite standard (b).  Note the co-migration of the 
peaks from each.  Mobile phase and detection conditions are the same as in the 
previous overlay. 
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co-eluent with a 5 µM nitrite standard in saline.  It was believed that the interferent 
was nitrite as a nitroglycerin impurity present in small amounts.  The 
shift in retention time of the nitrite present in the nitroglycerin sample from that of 
the 5 µL nitrite standards was likely due to the presence of ethanol (15%) and 
propylene glycol (15%) from the nitroglycerin concentrated solution (5 mg/mL).  
Spiking of the nitroglycerin sample with 1 µM nitrite shows a co-elution in Figure 
4.4.  Nitroglycerin itself is in an oxidized form, and was unlikely to be an 
interferent.  Furthermore, ethanol and propylene glycol present from the 
concentrated nitroglycerin solution were unlikely to oxidize at a potential of +1.025 
V.  Stability of the nitroglycerin solution was tested by examining changes in nitrite 
produced over time at room temperature.  Fresh 2.5 mg/mL nitroglycerin solution 
was injected into the LC-EC system, generating a response for nitrite equal to 
approximately 750 nM.  This response would be equal to 1.5 µM nitrite in the 
nitroglycerin concentrated solution (5 mg/mL).  The vial containing the solution 
(2.5 mg/mL nitroglycerin) was then left out for a 24 hour period.  At the end of this 
period, the nitroglycerin solution was injected, generating a response for nitrite 
unchanged from that produced by the fresh solution, shown in Figure 4.5.   
    
4.7   Analysis of sheep subcutaneous microdialysis samples 
4.7.1  Sheep Experiment 
Dialysate samples from ongoing sheep experiments at Purdue University 
(West Lafayette, IN) were examined.  All sheep had 1 cm linear microdialysis 
probes with a polyacrylonitrile membrane possessing a 30 kDa molecular weight  
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Figure 4.5:  Overlay of two nitroglycerin samples injected from the nitroglycerin 
stability study.  Trace (a) is a 2.5 mg/mL fresh nitroglycerin sample containing 750 
nM nitrite.  Trace (b) is a 2.5 mg/mL nitroglycerin sample after 24 hours.  No 
significant change in nitrite is evident.  Mobile phase and detection conditions are 
the same as in the previous overlay. 
 
 
102 
 
cutoff (BASinc, West Lafayette, IN) implanted subcutaneously.  The probes were 
perfused with 0.9% w/w saline (NaCl) solution (Fisher Scientific) at a rate of 1 µL 
per minute.  Dialysate samples were collected every 10 minutes.  Basal dialysate 
was collected for 60 minutes, followed by administration of the pharmacological 
agent and collection for the remainder of the experiment of approximately 120 
minutes. 
 
4.7.2 Analysis of nitroglycerin perfused subcutaneous dialysate 
After a basal collection period of 60 minutes, the syringe containing 0.9% 
saline solution was switched with that one containing 5mg/mL of nitroglycerin in 
saline.  Nitrite concentrations were measured starting at the 10 minute mark, with 
an increase in nitrite levels with each subsequent time point thereafter to peak at 
100 minutes.  After a peak in nitrite levels, a slight decrease occurred for the 
remainder of the experiment.  Confirmation of nitrite peak identity was determined 
by spiking the sample with a nitrite standard.  An example chromatogram overlay 
comparing nitrite levels in basal samples to that during nitroglycerin administration 
is shown in Figure 4.6. 
 
 
Concentration changes in nitrite during these experiments were evaluated 
using the developed LC-EC method.  An increase in nitrite occurred from infusing 
nitroglycerin in these experiments as shown in the time-course plot in Figure 4.7.  
In these nitroglycerin infusion experiments, sheep nitrite concentration peaked at  
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Figure 4.6:  Overlay of chromatograms from the 0 time point of basal collection 
and 100 minutes after switching the syringe containing saline to that containing 
nitroglycerin (5mg/mL) in saline.  Trace (a) is under basal conditions and trace (b) 
is during nitroglycerin infusion.  Mobile phase conditions are 1 mM TBAOH and 15 
mM H2SO4 at pH 4.0. 
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Figure 4.7:  Time-course plot of change in nitrite concentration as a result of 
nitroglycerin infused subcutaneously in multiple sheep at the 60 minute mark.  An 
n of 3 was collected for these experiments, with error bars representing standard 
deviation from average concentration.  The average maximum nitrite production 
was approximately 17 µM, taking recovery into account.   
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Figure 4.8:  Time course graph of nitrite normalized response as a function of 
following nitroglycerin (5mg/mL) infusion through the microdialysis probe 
subcutaneously implanted in sheep.  Normalization was accomplished by dividing 
each response by the maximum response in that experiment and multiplying the 
value to 100 to obtain a percentage.  The lined scatter plot trace is response 
based upon the LOS collection, separation, and amperometric detection method, 
and is shifted to take in account lag time.  The transparent bar graph is response 
using the developed LC-EC detection method. 
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an average of approximately 17 µM, taking recovery into account.  The LOS has 
not yet been validated as a quantitative tool.  However, the developed LC-EC 
method had been validated, and was used to quantitate the nitrite concentrations 
present in spiked basal dialysate in at the end of chapter 2 of this thesis.  Figure 
4.8 shows the normalized responses for both methods, relative to the amount of 
nitrite present with respect to time during these experiments.  Responses were 
normalized by dividing the response at each time point by the maximum response 
in the experiment.  These values were then multiplied by 100 to convert to a 
percentage.  An increase in nitrite levels within the first vial collection from the 
start of nitroglycerin perfusion was expected, as the environment of nitroglycerin 
action adjacent to the probe was monitored.  A significant lag time of 50 minutes 
prior to an increase in response was observed with the ‘LOS’-Pinnacle Board 
method, or the scatter-line plot.  This lag time was calculated using the distance 
between the microdialysis probe and the “LOS”-Pinnacle system as well as the 
dimensions of tubing required.  Figure 4.9 shows the schematic of this system [5].  
A lag time of 5 minutes prior to an increase in response was observed with the 
developed LC-EC system.  This lag time was calculated using the distance 
between the microdialysis probe and the collection vial as well as the dimensions 
of tubing required.   A comparison was made of the normalized response of the 
‘LOS’-Pinnacle system versus the normalized response of the developed LC-EC 
system for these experiments.  When plotted, these values should be arranged in 
a linear fashion, and ideally, fitted with a line with R2 coefficient of close to 1.   
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Figure 4.9:  Schematic of the ‘LOS’-Pinnacle Board system.  Image reproduced 
with permission of DE Scott.   
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Figure 4.10:  Comparison of normalized ‘LOS’-Pinnacle Board and conventional 
LC-EC systems.  The points plotted show linearity; however, the R2 coefficient of 
0.852 is far below that of a desired value of 1.  Furthermore, the slope should be 
close to 1, ideally. 
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The plotted data points were linear but somewhat scattered with an R2 
coefficient of 0.852, as shown in Figure 4.10.  Furthermore, the slope of this line 
was 0.409 and ideally should be close to 1.  When the response of each system is 
normalized, if the response of one system doubles so too should that of the other.  
The LC-EC method developed was evaluated for linearity, and was determined to 
have an R2 coefficient of 0.999.  As a result of this validation, it is unlikely that the 
LC-EC system is problematic when evaluating nitrite within its linear range.  The 
‘LOS-Pinnacle Board system has been able to qualitatively measure an increase 
in response as a result of elevated nitrite levels, however it has not been 
validated.  The advantage of using the validated LC-EC method is that it is 
capable of quantitation. 
 
4.7.3 Analysis of topical nitroglycerin cream subcutaneous dialysate 
As an alternative method for the detection of nitric oxide products,  
nitroglycerin cream was evaluated.  After a basal collection period of 60 
minutes, nitroglycerin cream was applied to the epidermis over the area where the 
microdialysis probe was implanted subcutaneously.  Two experiments involving 
the application of nitroglycerin cream occurred:  the first was a circular application 
with a diameter of 1.27 cm; the second was a circular application of a 2.54 cm 
diameter.  No substantial increase in nitrite levels was apparent throughout these 
experiments.  It is believed that the epidermal application was too removed from  
 
 
 
110 
 
 
Figure 4.11:  Overlay of chromatograms from the 0 time point of basal collection 
and 100 minutes after application of nitroglycerin cream (2%w/w).  Nitrite increase 
is minimal as was expected.  Trace (a) is under basal conditions and trace (b) is 
after nitroglycerin cream application.  Mobile phase and detection conditions are 
the same as the previous chromatograms in this chapter. 
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the microdialysis probe implantation site and any nitric oxide and nitrite generated 
is too far away to diffuse into the microdialysis probe for collection.   The 
epidermis is known for its vascularity; it could be possible that nitroglycerin is 
absorbed into the epidermis at the application site and is distributed into the 
vasculature in the epidermal tissue surrounding.  Studies conducted with 
microdialysis probes implanted just below the surface of the skin with 
administration of nitroglycerin in a patch (Transderm Nitro Patches, Ciba) show an 
increase in nitrite production by a factor of 10 [9].  Figure 4.11 shows a 
comparison of a chromatogram under basal conditions with that after nitroglycerin 
cream application.    
 
4.7.4 Analysis of NO in subcutaneous dialysate, produced by epidermal 
histamine injection 
After a basal collection period of 60 minutes, 0.5 mL of a 0.1 mg/mL 
concentration of histamine was injected into the epidermis in the area over where 
the site of microdialysis probe implantation. No substantial increase in nitrite 
concentration was apparent from this injection throughout the experiment.  It is 
again believed that the epidermal injection was too far away from the 
microdialysis probe implantation site, such that any nitric oxide and nitrite 
generated cannot diffuse into the microdialysis probe for collection.  Studies 
conducted with microdialysis probes implanted just below the surface of the skin 
with administration of 15µL  of histamine at a concentration of 1µM showed an 
increase in nitrite production by a factor of 3 [9].  Figure 4.12 shows an overlay of  
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Figure 4.12:  Overlay of chromatograms from the 0 time point of basal collection 
and 100 minutes after a 0.5 mL injection of histamine (0.1 mg/mL).  Nitrite  
increase is minimal as was expected. Trace (a) is under basal conditions and 
trace (b) is after histamine injection.  Mobile phase and detection conditions are 
the same as the in the previous figure. 
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chromatograms from two time points of the histamine injection experiment in 
sheep.   From the graphs, a slight increase is noticed; however, it seems likely 
that the proximity of the probe to the injection site has an influence on nitrite 
production, as the concentration (0.1 mg/mL or 0.9 mM) and volume (0.5 mL) 
injected were significantly higher in comparison to those injected in the Clough 
study [9].    
 
4.8 Summary 
 In the previous chapters, an LCLC-EC-UV/Vis system was developed to 
evaluate changes in nitrite and nitrate in dialysate from multiple locations in 
multiple animals.  Chromatographic conditions were optimized for separation of 
nitrite and nitrate from many other compounds present in dialysate.  In addition, 
detection parameters were optimized for EC and UV/Vis detection systems to 
obtain detection limits for nitrite and nitrate as low as possible and to reduce the 
likelihood of interferents.  In vitro studies were conducted to evaluate the recovery 
of nitrite and nitrate from a microdialysis probe used in rat brain experiments.  In 
addition, in vitro production of nitrite from the nitric oxide donor DEA NONOate 
was monitored as a proof of concept that the chromatographic and detection 
systems are capable of separating and identifying nitrite in a best case scenario in 
preparation for animal studies.   
 
 Experiments were conducted to determine whether or not damage 
occurring in the brain of the rat as a result of 3-MPA administration was influenced 
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by RNS formation and activity.  It was determined that 3-MPA does not 
significantly increase nitric oxide production, and therefore, does not result in RNS 
generation.  In addition, studies of nitric oxide production in sheep subcutaneous 
skin layers were conducted.  First, in vitro nitroglycerin delivery studies were 
conducted to determine the % delivery to the probe sampling site.  Then, in a 
proof of concept scenario, the formation of nitrite from nitric oxide production as a 
result of nitroglycerin perfusion at the microdialysis probe sampling site was 
investigated.  Nitrite concentrations increased substantially from that present 
under basal conditions.  This finding sheds light on the role of production of NO 
from nitroglycerin and its role in vasodilatation.  Furthermore, comparison of levels 
of nitric oxide production detected and quantified by this method to that 
determined by the S. Lunte group method showed that these methods are 
complementary to one another.  However, it is clear that further development of 
the ‘Lab on a Sheep’-Pinnacle system is necessary for its application as a tool for 
nitrite quantitation. 
 
 Studies of nitrite formation as a result of epidermal application of 
nitroglycerin cream showed that a difference in distance of probe location from the 
application site minimized the collection of nitrite at the probe sampling site.  
Histamine injection studies had a similar outcome.  Injection of histamine in the 
epidermal region allowed for minimal transfer to the probe implantation site in the 
subcutaneous region, minimizing the generation of nitric oxide and the formation 
of nitrite in the probe sampling area. 
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4.9  Future directions 
 
Further animal studies need to be conducted.  Further in vitro calibration 
studies are needed to validate the ‘LOS’-Pinnacle Board system.  Analysis of split 
in vitro microdialysis samples will allow for a better comparison between this 
system and the LC-EC method developed in this thesis.  Further collaboration 
with the S. Lunte research group to examine the generation of NO in rats from 
nitroglycerin infusion are planned.  The developed LC-EC method will be used to 
validate the ‘LOS’-Pinnacle Board system.  Implementation of these methods in 
studying nitroglycerin-based NO generation in rats will serve to validate their 
broad applicability.  
 
 As an independent project of the C. Lunte research group, it is desired to 
administer NO donors and NOS upregulators into the hippocampus brain regions 
of rats to study its influence on the production of RNS and to further evaluate the 
legitimacy of the rat as a model of oxidative stress in the brain.  In addition, 
examination of RNS production in rats as a result of chemotherapeutics 
administration will commence.  Increases in RNS as a result of 
chemotherapeutics administration will add additional support to GABA/glutamate 
studies in these models.     
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